Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,Cell cycle,0.5825952326852378,2.033586828560625,0.0,0.0,0.0,52/124,20.27%,BUB1;BUB1B;RAD21;CDK2;ORC1;ANAPC1;PLK1;PRKDC;MCM6;TTK;CDC6;CDC25A;PCNA;SMC1A;E2F1;YWHAE;CHEK1;CDK1;MCM2;MCM3;MCM5;CDC26;YWHAH;PTTG1;STAG1;MAD2L1;ORC3;CCND3;CCNB2;CDK6;PKMYT1;ORC6;ESPL1;CDC27;CDC25C;SMC3;BUB3;YWHAZ;CDC7;CDC45;MCM7;ANAPC2;MCM4;CCNB1;RB1;CDC23;ORC4;HDAC2;ORC2;E2F3;YWHAB;CDC20
gsea,Oocyte meiosis,0.533232692158638,1.9424642330425153,0.02127659574468085,0.006937745789122208,0.01,40/129,22.35%,BUB1;CDK2;ANAPC1;PLK1;SMC1A;YWHAE;CDK1;CDC26;FBXO5;PPP1CC;YWHAH;PPP3R1;PTTG1;MAD2L1;MAP2K1;CCNB2;SLK;PKMYT1;PPP2CA;ESPL1;PPP1CA;PPP2R1B;CDC27;CDC25C;SMC3;YWHAZ;ADCY3;PPP2R5A;ANAPC2;CCNB1;MAPK1;CDC23;PRKACB;YWHAB;CDC20;MAPK12;ANAPC10;RPS6KA3;AURKA;SKP1
gsea,Homologous recombination,0.60435711325026,1.888845278423716,0.0,0.03237614701590364,0.04,13/41,19.35%,BRCA1;TOPBP1;RAD54L;XRCC2;RPA3;RPA1;POLD3;RPA2;RBBP8;UIMC1;RAD51;POLD1;RAD50
gsea,Progesterone-mediated oocyte maturation,0.4778885315925538,1.8453358982755241,0.0,0.04162647473473325,0.08,29/100,23.39%,BUB1;CDK2;ANAPC1;PLK1;CDC25A;CDK1;KIF22;CDC26;HSP90AA1;MAD2L1;MAP2K1;CCNB2;PKMYT1;PIK3CB;CDC27;CDC25C;ADCY3;ANAPC2;CCNB1;HSP90AB1;MAPK1;CDC23;PRKACB;MAPK12;ANAPC10;RPS6KA3;AURKA;KRAS;MAPK8
gsea,Nucleotide excision repair,0.5275836984656175,1.835561450698461,0.0,0.036076278103435486,0.08,19/47,19.61%,PCNA;POLE;RFC3;POLE2;RFC5;RFC2;RPA3;ERCC5;RPA1;POLD3;RAD23B;RPA2;RFC1;DDB2;GTF2H1;RFC4;POLD1;CETN2;LIG1
gsea,RNA transport,0.4571844082751031,1.8243113372777569,0.0,0.03700131087531844,0.09,66/186,28.70%,NDC1;NUP188;NUP50;SEH1L;NUP62;SRRM1;NCBP1;NUP153;THOC3;NXT2;TACC3;EIF5B;GLE1;XPO1;THOC1;NUP205;UPF2;EIF2S2;XPOT;NUP210;NUP43;PRMT5;EIF4E;POM121C;NUP58;DDX20;DDX19A;GEMIN5;EIF3CL;NUP35;RAN;NUP133;TPR;RANBP2;RPP40;TARDBP;NUP107;NUP85;POP7;SNUPN;NUP37;EIF1AX;EIF2S1;NUP214;NUP93;NUP88;XPO5;THOC7;GEMIN4;EIF3E;EIF2S3;NUP155;DDX19B;CYFIP1;FUS;POP5;EIF4G3;TRNT1;EIF2B1;RPP30;PABPC1;EIF4G1;RPP25;SUMO1;KPNB1;ENST00000630137.2
gsea,Lysine degradation,0.48070043312322963,1.8194451285674225,0.0,0.031715409321701526,0.09,15/63,17.21%,PLOD2;SUV39H2;NSD2;NSD1;NSD3;ACAT2;DHTKD1;HADHA;EZH2;ASH1L;HADH;ALDH2;SUV39H1;ALDH9A1;COLGALT1
gsea,Mismatch repair,0.6879060825703239,1.7874959689223118,0.0,0.046829784076574905,0.14,14/23,19.61%,PCNA;EXO1;RFC3;RFC5;MSH2;RFC2;RPA3;RPA1;POLD3;RPA2;RFC1;RFC4;POLD1;LIG1
gsea,Base excision repair,0.5939510750957364,1.7505562684228166,0.020833333333333332,0.06321057274533567,0.19,15/33,20.52%,PCNA;NEIL3;POLE;HMGB1;POLE2;FEN1;PARP1;SMUG1;POLD3;PARP2;UNG;MBD4;POLD1;LIG1;PARP4
gsea,Fatty acid elongation,0.66262126793846,1.7436003922098944,0.0,0.06243971210209987,0.21,10/27,16.84%,HSD17B12;ELOVL6;HACD3;ELOVL5;ACOT7;TECR;HADHA;HADH;ELOVL7;THEM4
gsea,DNA replication,0.7215575014181766,1.7293752294449478,0.0,0.06559323291533724,0.22,25/36,20.18%,MCM6;PCNA;POLE;MCM2;MCM3;MCM5;RFC3;POLE2;RFC5;FEN1;RFC2;RPA3;DNA2;RPA1;POLD3;RPA2;RFC1;PRIM2;POLA1;MCM7;MCM4;RFC4;POLD1;LIG1;PRIM1
gsea,mRNA surveillance pathway,0.434641922233975,1.631414217774268,0.044444444444444446,0.1815376814820311,0.46,36/98,31.75%,BCL2L2-PABPN1;CPSF3;SRRM1;NCBP1;NXT2;RNGTT;GLE1;UPF2;PPP1CC;PAPOLA;CPSF2;DDX19A;PPP2CA;PPP1CA;HBS1L;PPP2R1B;CSTF2;TARDBP;NUDT21;PPP2R5A;CSTF3;CSTF1;GSPT1;DDX19B;FUS;CPSF7;SMG6;PABPC1;CPSF1;SMG5;PPP2R3A;ETF1;NXT1;PPP2R2C;PELO;PPP2CB
gsea,Cysteine and methionine metabolism,0.5539967484281925,1.626326330947788,0.0784313725490196,0.1739773174810646,0.48,18/50,25.73%,GOT2;PSAT1;AMD1;GCLM;SMS;AHCY;LDHA;MAT2B;GOT1;SRM;LDHB;ENOPH1;MTAP;APIP;BCAT1;PHGDH;MDH1;AHCYL1
gsea,Arginine and proline metabolism,0.49174524342630316,1.5960027356594304,0.01818181818181818,0.20912348021496943,0.53,12/50,19.40%,GOT2;AMD1;SMS;CKB;ALDH2;GOT1;ALDH18A1;ARG2;SRM;P4HA1;ALDH9A1;PYCR2
gsea,Ribosome biogenesis in eukaryotes,0.4559495032768788,1.5846843258298418,0.02040816326530612,0.21830773416437882,0.53,35/108,30.91%,RIOK1;NOP58;NXT2;XPO1;GAR1;WDR75;RBM28;RAN;WDR43;RPP40;BMS1;POP7;WDR3;NOL6;EFL1;RCL1;DKC1;NAT10;GNL3L;GNL2;HEATR1;FCF1;UTP4;UTP18;UTP15;SBDS;POP5;RPP30;UTP14A;NVL;RPP25;MDN1;GNL3;NXT1;GTPBP4
gsea,Biosynthesis of unsaturated fatty acids,0.5936978808903441,1.5708652376701322,0.022222222222222223,0.23675057505379538,0.55,7/27,11.94%,HSD17B12;ELOVL6;HACD3;ELOVL5;ACOT7;TECR;ELOVL7
gsea,Fanconi anemia pathway,0.5405164505439045,1.552148743358051,0.057692307692307696,0.25955331305186613,0.61,12/54,15.36%,USP1;FANCI;BRCA1;RMI2;RPA3;UBE2T;RPA1;RPA2;FANCL;FANCA;FANCC;RAD51
gsea,Pyruvate metabolism,0.5054653741731826,1.5051472563496926,0.06382978723404255,0.36461708425053385,0.66,15/47,27.12%,GLO1;ME1;ACAT2;PC;FH;LDHA;PDHA1;ALDH2;LDHB;ALDH9A1;PKM;ACACA;MDH1;DLD;ACAT1
gsea,Non-alcoholic fatty liver disease,-0.3785326402865033,-1.490694699415355,0.02702702702702703,1.0,0.77,54/155,27.36%,UQCR11;NDUFA1;ENST00000629738.3;NDUFA2;NR1H3;NDUFB10;NDUFA13;NDUFA10;COX5B;PIK3CD;COX7C;UQCRH;BAX;NDUFS7;UQCR10;COX6C;COX4I1;MAP3K11;IRS2;NDUFB4;NDUFS4;NDUFB7;NDUFA11;UQCRB;PRKAG1;NDUFC2-KCTD14;NDUFA8;SDHC;MAPK13;MAPK14;NDUFB9;UQCRC1;MAPK11;AKT2;MLX;IL6;NDUFS3;DDIT3;NDUFC2;TRAF2;COX7B2;UQCRQ;NDUFB2;NDUFB1;SDHD;NDUFB8;COX7A2;NDUFB3;NDUFS5;CASP3;IRS1;NDUFS6;NDUFB6;COX6B1
gsea,Proteasome,0.5048077310360684,1.4881417552976959,0.1320754716981132,0.3987378106169185,0.7,18/46,25.83%,PSMD14;PSMD6;PSMB2;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMB3;PSME1;PSMC3;PSMA6;PSMD13
gsea,Glycolysis / Gluconeogenesis,0.5162279491843359,1.4701792121758483,0.0784313725490196,0.4329153372412258,0.75,18/67,23.10%,GAPDH;ALDOA;HKDC1;LDHA;GPI;PGM2;PGK1;PDHA1;ALDH2;PGM1;ENO1;TPI1;LDHB;ALDH9A1;PKM;ENO2;ADPGK;PGAM1
gsea,Spliceosome,0.37346353354890377,1.4622304599063323,0.022222222222222223,0.4354261404791938,0.76,32/150,15.20%,SNRPD1;WBP11;RBM25;LSM3;NCBP1;THOC3;SNRPA1;SF3B3;HSPA8;AQR;SMNDC1;THOC1;U2AF1;DDX46;PHF5A;PRPF38A;SNRPF;DHX16;SRSF1;LSM5;SRSF7;SF3B1;SNRPD3;BCAS2;DDX5;U2AF1L5;SNRNP40;HNRNPM;HNRNPU;SRSF4;CDC5L;HNRNPC
gsea,Retrograde endocannabinoid signaling,-0.366128563030555,-1.4542105438749466,0.07692307692307693,1.0,0.84,30/148,24.58%,NDUFA1;NDUFA2;NDUFB10;NDUFA13;NDUFA10;MAPK3;NDUFS7;NDUFB4;NDUFS4;NDUFB7;NDUFA11;NDUFC2-KCTD14;NDUFA8;MAPK13;MAPK14;NDUFB9;MAPK11;PTGS2;ADCY6;GABRP;NDUFS3;NDUFC2;NDUFB2;NDUFB1;PRKCG;NDUFB8;ADCY7;FAAH;NDUFB3;NDUFS5
gsea,Basal cell carcinoma,-0.4550071544648534,-1.4525155350369168,0.10869565217391304,1.0,0.84,18/63,28.92%,GADD45A;WNT5A;PTCH1;BAX;DVL2;GADD45B;BAK1;DVL1;FZD7;DVL3;WNT5B;FZD2;WNT6;GLI2;WNT7B;TP53;CTNNB1;WNT10A
gsea,Thyroid hormone synthesis,0.479577259297111,1.4050417087645146,0.07547169811320754,0.6363805001113008,0.89,14/75,21.75%,GPX8;HSP90B1;TTF2;ATP1B3;GPX2;HSPA5;ADCY3;ATP1B1;GNAQ;GNAS;PRKACB;ATP1A1;CREB1;PDIA4
gsea,Oxidative phosphorylation,-0.3716211871862014,-1.380420011286236,0.0975609756097561,1.0,0.91,32/133,15.21%,UQCR11;NDUFA1;NDUFA2;NDUFB10;NDUFA13;NDUFA10;ATP5MF;ATP5MC2;COX5B;ATP6V0B;ATP5F1E;COX7C;ATP6V1G1;UQCRH;ATP5ME;NDUFS7;UQCR10;COX6C;COX4I1;NDUFB4;COX11;NDUFS4;NDUFB7;NDUFA11;UQCRB;NDUFC2-KCTD14;NDUFA8;ATP5PB;SDHC;LHPP;NDUFB9;UQCRC1
gsea,"Alanine, aspartate and glutamate metabolism",0.4150415029821062,1.3777738363740433,0.1111111111111111,0.7197157153411126,0.95,11/37,35.00%,GOT2;GFPT1;GLS;PPAT;GOT1;GPT2;CAD;GLUL;ASNS;ADSL;GLUD1
gsea,Terpenoid backbone biosynthesis,0.5506615464592801,1.347372528690746,0.1276595744680851,0.8336857856595186,0.95,13/22,27.12%,ACAT2;PDSS1;IDI1;HMGCS1;PDSS2;DHDDS;GGPS1;PCYOX1;MVD;FDPS;ZMPSTE24;NUS1;ACAT1
gsea,Thermogenesis,-0.3248846152366698,-1.3444738539864876,0.0975609756097561,1.0,0.93,62/232,24.58%,UQCR11;NDUFA1;NDUFA2;NDUFB10;NDUFA13;NDUFA10;ATP5MF;ATP5MC2;COX5B;ATP5F1E;COX7C;UQCRH;ACTL6A;COX14;PNPLA2;ATP5ME;AKT1S1;COA5;COA3;NDUFS7;UQCR10;COX6C;COX4I1;ACTG1;SMARCC1;NDUFB4;COX11;NDUFS4;NDUFB7;NDUFA11;UQCRB;PRKAG1;NDUFC2-KCTD14;NDUFA8;ATP5PB;SDHC;MAPK13;MAPK14;NDUFB9;UQCRC1;MAPK11;SMARCA4;CPT1A;ADCY6;NDUFS3;COX17;NDUFC2;COX7B2;UQCRQ;NDUFAF1;NDUFB2;NDUFB1;TSC2;SDHD;KDM3B;NDUFB8;COX7A2;GRB2;ADCY7;NDUFB3;SMARCD2;NDUFS5
gsea,NF-kappa B signaling pathway,-0.3712779226068576,-1.337700765899609,0.16326530612244897,1.0,0.93,18/104,24.99%,LTBR;GADD45A;TRADD;RELB;TICAM1;PIAS4;CFLAR;TAB1;GADD45B;TAB2;UBE2I;PTGS2;RIPK1;TRAF2;NFKB2;NFKBIA;TAB3;CSNK2A2
gsea,Staphylococcus aureus infection,-0.4982897218310133,-1.3375577985306926,0.14285714285714285,1.0,0.93,10/95,31.68%,C1R;HLA-DMA;C1S;KRT16;ITGAM;ICAM1;KRT18;C3;HLA-DQB1;KRT19
gsea,Aminoacyl-tRNA biosynthesis,0.42721684283879513,1.3342896772269268,0.11627906976744186,0.8602804778511538,0.95,6/66,17.13%,FARSB;GATC;MARS2;IARS2;LARS2;WARS2
gsea,Amino sugar and nucleotide sugar metabolism,0.42771805311387234,1.3271676022355827,0.16326530612244897,0.8629488416162008,0.95,10/48,14.99%,UGDH;GNPNAT1;HKDC1;NANS;GPI;GFPT1;PGM2;PGM1;GALE;PGM3
gsea,Leishmaniasis,-0.3982485688585975,-1.326087884034586,0.14893617021276595,1.0,0.93,12/77,18.97%,MARCKSL1;PTPN6;MAPK3;TAB1;EEF1A1;TAB2;MAPK13;MAPK14;HLA-DMA;MAPK11;PTGS2;ITGAM
gsea,Glutathione metabolism,0.38673309230016634,1.3084474210921084,0.2037037037037037,0.9188658867370747,0.97,7/57,8.89%,RRM1;GPX8;GCLM;SMS;CHAC2;GPX2;ANPEP
gsea,Protein export,0.4611604601638725,1.2969863330164169,0.21739130434782608,0.9385778946141046,0.98,10/23,23.19%,SRPRA;SEC63;SPCS3;HSPA5;SRP14;SEC61G;SRP9;SRPRB;SEC11C;SRP72
gsea,Purine metabolism,0.3734076599132781,1.2712225220416213,0.20833333333333334,1.0,0.98,19/129,23.07%,RRM1;HPRT1;ATIC;GART;NME1;DCK;PNP;ADK;PDE8A;PGM2;PPAT;PGM1;ADCY3;PFAS;NUDT5;PKM;AK2;GMPS;PDE2A
gsea,Ferroptosis,0.3894852021073672,1.2593973731298664,0.15384615384615385,1.0,0.98,8/41,11.23%,GCLM;SLC7A11;TFRC;ACSL3;VDAC3;SLC39A14;SLC3A2;SLC39A8
gsea,beta-Alanine metabolism,0.3855234919599261,1.2502885725591364,0.1111111111111111,1.0,0.98,4/30,16.38%,DPYD;HADHA;ALDH2;ALDH9A1
gsea,ABC transporters,0.5002653393217522,1.248187034904103,0.21951219512195122,1.0,0.98,3/45,10.38%,ABCC2;ABCD3;ABCB10
gsea,Complement and coagulation cascades,-0.430755701808957,-1.245916473361154,0.24489795918367346,1.0,0.97,12/85,33.53%,SERPINF2;CD59;C8G;PROC;C1R;C1S;ITGAM;C3;CLU;SERPINE1;CD55;PLAT
gsea,Gap junction,0.3560563815654832,1.2386401885366976,0.2,1.0,0.99,15/88,20.57%,TUBB;CDK1;TUBA1B;MAP2K1;SOS1;TUBB4B;TUBA4A;ADCY3;MAP3K2;MAPK1;GNAQ;GNAS;NRAS;PRKACB;TUBB2A
gsea,Spinocerebellar ataxia,0.32191177054556147,1.2308602776560365,0.19148936170212766,1.0,0.99,33/143,26.67%,SLC25A5;PSMD14;PSMD6;PSMB2;VDAC3;PSMD1;AFG3L2;PSMA5;PUM2;PSMD11;PSMA4;PSMA3;OPA1;PIK3CB;PSMD7;ENST00000629691.2;PIK3C3;MCU;PSMC6;PIK3R4;PSMA1;GNAQ;PSMB3;XBP1;PSMC3;RBPJ;AMBRA1;CYCS;MAPK8;MTOR;PSMA6;PSMD13;ATXN2
gsea,Metabolism of xenobiotics by cytochrome P450,-0.40273193057570494,-1.2305703689712995,0.25,1.0,0.99,10/76,28.71%,CBR1;MGST2;MGST3;CBR3;ALDH3A1;ALDH3B1;UGT1A6;GSTP1;GSTK1;AKR1C1
gsea,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.36338763192344203,1.2270981586301541,0.1836734693877551,1.0,0.99,4/26,13.05%,DPM2;PIGU;PIGN;PIGH
gsea,Chemical carcinogenesis,0.3010021593758423,1.2251102736680708,0.1568627450980392,1.0,0.99,45/239,33.27%,CDC6;CDC25A;E2F1;HSP90B1;HSP90AA1;KPNA2;KPNA4;CCND3;MAP2K1;SOS1;PIK3CB;PTGES3;ADCY3;BIRC5;HSP90AB1;STAT5B;MAPK1;RB1;GNAS;RNA5SP498;ARNT;NRAS;PRKACB;VEGFA;KPNA1;KPNA3;CREB1;RPS6KA3;AKR1C2;UGT1A3;KRAS;MTOR;RPS6KB2;RAF1;PIK3CA;MGST1;KPNB1;BCL6;PPARA;UGT1A1;SULT1A4;EPHX3;NOTCH2;VDR;RPS6KB1
gsea,Coronavirus disease,-0.32090350949160856,-1.2157260621589459,0.225,1.0,0.99,53/232,23.74%,RPL37;RPL28;RPS13;RPL37A;RPL10A;RPS18;RPL11;RPL13;RPL39;PIK3CD;MAPK3;RPS29;RPL13A;RPS2;RPL29;RPS21;RPL9;EGFR;RPL36AL;RPL27A;RPS12;RPLP2;RPLP1;RPL8;RPL31;C8G;RPL34;RPL27;TAB2;STAT2;C1R;RPL23A;MAPK13;MAPK14;FAU;RPL10;RPL7;MAPK11;RPL14;C1S;IL6;RPL35;RPL18A;RPL7A;RPL12;RPS14;PRKCG;MAVS;RPS8;RPS5;RPS20;RPLP0;NFKBIA
gsea,Ubiquitin mediated proteolysis,0.28265086505946413,1.2019140262371113,0.21052631578947367,1.0,0.99,53/140,36.93%,ANAPC1;BRCA1;UBE2A;UBE2C;CDC26;UBA1;HUWE1;UBA6;UBE2E3;FANCL;CDC27;DDB2;STUB1;PIAS1;RPS27A;ANAPC2;UBE2G1;ELOC;ELOB;UBE4A;CUL2;CDC23;CUL5;UBE2K;CDC20;ANAPC10;COP1;SKP1;CUL1;UBE4B;CUL4B;UBE2N;PRPF19;HERC4;DDB1;TRIM37;TRIP12;NEDD4L;UBE2L3;SMURF2;NEDD4;ANAPC7;RBX1;UBE2S;BIRC2;CBL;BIRC3;XIAP;UBE2D1;TRIM32;UBE2J1;UBE3C;ANAPC5
gsea,Pyrimidine metabolism,0.3896301520379184,1.1883567642267292,0.3076923076923077,1.0,0.99,11/56,21.32%,RRM1;TYMS;DPYD;NME1;DCK;PNP;DUT;UMPS;TK1;CMPK1;DTYMK
gsea,Hepatitis C,0.2849332857347811,1.1875719123919446,0.19607843137254902,1.0,0.99,31/157,23.29%,CDK2;E2F1;YWHAE;OAS3;EIF2AK4;YWHAH;MAP2K1;CDK6;PPP2CA;SOS1;JAK1;PPP2R1B;PIK3CB;YWHAZ;TBK1;LDLR;PIAS1;STAT1;EIF2S1;MAPK1;RB1;NRAS;EIF2AK2;E2F3;YWHAB;EIF3E;BID;IFNAR1;CYCS;GSK3B;KRAS
gsea,Tryptophan metabolism,0.42964908291096393,1.1817671462850203,0.32727272727272727,1.0,0.99,6/42,16.38%,ACAT2;DHTKD1;HADHA;HADH;ALDH2;ALDH9A1
gsea,Pentose phosphate pathway,0.511338379396256,1.1807330237623825,0.2692307692307692,1.0,0.99,5/30,14.52%,ALDOA;GPI;PGM2;PGM1;RPE
gsea,RNA degradation,0.319125889225297,1.177208287215174,0.23684210526315788,1.0,0.99,18/79,16.86%,EXOSC8;LSM3;HSPD1;HSPA9;CNOT9;DIS3L;PNPT1;PATL1;LSM5;TENT4A;PAN3;DIS3;TTC37;ENO1;CNOT7;LSM1;MPHOSPH6;EXOSC10
gsea,Cardiac muscle contraction,-0.3585809833564933,-1.175142826106308,0.21739130434782608,1.0,1.0,13/87,16.56%,UQCR11;COX5B;COX7C;ATP2A2;TPM1;UQCRH;UQCR10;COX6C;COX4I1;UQCRB;CACNB3;UQCRC1;TNNC1
gsea,Human T-cell leukemia virus 1 infection,0.3083877157947246,1.1733560490881076,0.22727272727272727,1.0,1.0,44/219,25.71%,BUB1B;SLC25A5;CDK2;ANAPC1;E2F1;CHEK1;MAP2K4;CDC26;XPO1;PPP3R1;PTTG1;MAD2L1;VDAC3;CCND3;MAP2K1;CCNB2;RAN;ESPL1;JAK1;PIK3CB;CDC27;TRRAP;ETS2;BUB3;ADCY3;ANAPC2;STAT5B;MAPK1;RB1;CDC23;NRAS;PRKACB;E2F3;CDC20;ANAPC10;CREB1;RANBP1;KRAS;MAPK8;ATR;FDPS;CANX;CCNE1;SLC2A1
gsea,Amyotrophic lateral sclerosis,0.3085329876272479,1.161552899584733,0.24489795918367346,1.0,1.0,73/364,18.24%,NDC1;NUP188;NUP50;SEH1L;NUP62;GPX8;UQCRFS1;TUBB;NCBP1;NUP153;TUBA1B;ANXA7;NXT2;CHMP2B;GLE1;PSMD14;NUP205;PSMD6;PSMB2;PPP3R1;WDR41;NUP210;NUP43;RAB8A;ENST00000639558.1;POM121C;NUP58;PSMD1;KIF5B;GPX2;NUP35;PFN2;NDUFS1;PSMA5;PSMD11;PSMA4;HNRNPA2B1;SRSF7;SETX;NUP133;PSMA3;TPR;RANBP2;FIG4;TUBB4B;DNAH14;PSMD7;NEFH;TARDBP;NUP107;HSPA5;NUP85;TUBA4A;TBK1;ENST00000629691.2;SIGMAR1;ALS2;NUP37;PIK3C3;MCU;ATP5PF;PFN1;PSMC6;PIK3R4;EIF2S1;NDUFB5;PSMA1;UBQLN1;NUP214;NUP93;NUP88;UBQLN2;PSMB3
gsea,Cushing syndrome,0.27935621728361837,1.155568487566633,0.2857142857142857,1.0,1.0,21/155,19.48%,CDK2;E2F1;FH;WDR5;MAP2K1;PDE8A;CDK6;USP8;RAP1B;NCEH1;LDLR;ADCY3;MAPK1;GNAQ;RB1;GNAS;RNA5SP498;ARNT;TCF7;PRKACB;E2F3
gsea,Porphyrin and chlorophyll metabolism,0.4157307404604775,1.1517150590048606,0.3333333333333333,1.0,1.0,11/43,33.03%,COX15;BLVRA;UROS;FXN;UGT1A3;EARS2;HMOX1;FECH;UGT1A1;HCCS;ALAS1
gsea,"Parathyroid hormone synthesis, secretion and action",-0.3058155590769822,-1.1474639087154204,0.21621621621621623,1.0,1.0,12/106,17.38%,PLD2;MMP14;NACA;MAPK3;JUND;EGFR;MMP15;ATF6B;ARHGEF1;ARRB2;ARRB1;ADCY6
gsea,PI3K-Akt signaling pathway,0.2789016700699062,1.1465175195785204,0.2708333333333333,1.0,1.0,64/354,33.27%,CDK2;BRCA1;YWHAE;HSP90B1;HSP90AA1;FN1;YWHAH;EIF4E;CCND3;MAP2K1;CDK6;PPP2CA;SOS1;JAK1;PPP2R1B;PIK3CB;OSMR;KITLG;YWHAZ;PPP2R5A;GNG12;LAMC1;HSP90AB1;MAPK1;THEM4;ITGB1;ITGA6;NRAS;ITGA3;IL4R;GNB4;PRKAA1;VEGFA;YWHAB;ITGB4;CREB1;PDPK1;IFNAR1;GSK3B;KRAS;MTOR;YWHAQ;LAMA5;PKN2;RPS6KB2;LAMA3;SPP1;CCNE1;RAF1;RPTOR;PIK3CA;LPAR5;ITGA5;PPP2R3A;CHUK;PPP2R2C;CDK4;PTK2;PPP2CB;EPHA2;VEGFC;LAMC2;GNG10;RPS6KB1
gsea,Citrate cycle (TCA cycle),0.40356015425488234,1.1378575015867771,0.26666666666666666,1.0,1.0,12/30,30.45%,IDH3A;PC;FH;PDHA1;SUCLG1;ACO1;SDHB;MDH1;DLD;IDH1;OGDH;CS
gsea,"Valine, leucine and isoleucine degradation",0.39624605232125976,1.1355266514246654,0.29411764705882354,1.0,1.0,15/48,32.73%,ACAT2;HADHA;HMGCS1;HADH;ALDH2;AACS;ALDH9A1;BCAT1;DLD;ACAT1;MCCC2;HSD17B10;ACADM;MMUT;IVD
gsea,Regulation of actin cytoskeleton,0.2804009589356282,1.1319831759705403,0.2830188679245283,1.0,1.0,38/218,20.47%,PIP4K2A;ARPC2;NCKAP1;FN1;PPP1CC;IQGAP1;MYH14;DIAPH3;MAP2K1;ROCK2;MSN;IQGAP3;PFN2;SOS1;PPP1CA;PIK3CB;WASL;ENAH;DIAPH1;ACTR2;ACTR3;BAIAP2;VCL;CRK;PIP5K1A;PFN1;GNG12;RHOA;MAPK1;ARPC3;ITGB1;ROCK1;ITGA6;NRAS;ITGA3;ITGB4;PPP1R12A;ARPC1A
gsea,Inositol phosphate metabolism,0.28916943517766924,1.1290565933141756,0.3488372093023256,1.0,1.0,12/73,19.79%,PIP4K2A;PI4K2B;MTMR6;SACM1L;PIK3CB;FIG4;PIK3C3;PIP5K1A;TPI1;IMPA2;PIK3C2A;PI4KA
gsea,Pertussis,-0.3322935904534951,-1.1248168825012674,0.26666666666666666,1.0,1.0,15/76,27.03%,TICAM1;MAPK3;PYCARD;C1R;MAPK13;MAPK14;MAPK11;C1S;IL23A;IL6;ITGAM;CALM3;CASP3;IRF1;C3
gsea,Protein processing in endoplasmic reticulum,0.326931342345713,1.1197663505367752,0.36585365853658536,1.0,1.0,56/171,28.02%,SVIP;BAG2;UGGT1;NSFL1C;HSP90B1;HSPA8;EIF2AK4;HSP90AA1;P4HB;SSR3;RAD23B;SEC63;RPN2;HSPA4L;SSR1;LMAN1;DNAJC3;DNAJC1;PDIA6;HSPA5;STUB1;PLAA;RPN1;SAR1B;SEC61G;UBE2G1;EDEM1;EIF2S1;UBQLN1;HSP90AB1;CKAP4;UBQLN2;EIF2AK2;VCP;XBP1;ERO1A;PDIA4;TXNDC5;SKP1;NFE2L2;MAPK8;SEC23A;HSPH1;CUL1;DNAJB11;DNAJA1;MAN1A1;UBE4B;MBTPS2;CANX;SEL1L;TRAM1;STT3A;WFS1;RRBP1;SEC23B
gsea,Ribosome,-0.3013629227976011,-1.1169483917011536,0.34782608695652173,1.0,1.0,34/158,14.68%,RPL37;RPL28;RPS13;RPL37A;RPL10A;RPS18;RPL11;RPL13;RPL39;RPS29;RPL13A;RPS2;RPL29;RPS21;RPL9;MRPS21;MRPL28;RPL36AL;RPL27A;RPS12;RPLP2;RPLP1;RPL8;RPL31;MRPL36;RPL34;RPL27;MRPL33;MRPL34;MRPS7;RPL23A;FAU;RPL10;RPL7
gsea,Cellular senescence,0.2816992275422228,1.1022537481418953,0.30434782608695654,1.0,1.0,17/156,10.05%,SLC25A5;CDK2;CDC25A;E2F1;MYBL2;CHEK1;CDK1;FOXM1;PPP1CC;PPP3R1;VDAC3;CCND3;MAP2K1;CCNB2;CDK6;PPP1CA;PIK3CB
gsea,Thyroid hormone signaling pathway,0.2890846560383492,1.1010168720896827,0.29545454545454547,1.0,1.0,34/121,34.75%,MED17;SIN3A;ATP1B3;MAP2K1;TBC1D4;PIK3CB;HDAC3;STAT1;ATP1B1;MAPK1;NRAS;BMP4;NOTCH1;PRKACB;HDAC2;ATP1A1;HIF1A;PDPK1;GSK3B;KRAS;MTOR;MED13;SLC2A1;RAF1;DIO2;PIK3CA;MED27;NOTCH3;MED24;ACTB;PFKL;NOTCH2;KAT2A;MED14
gsea,Long-term potentiation,0.34189828454466625,1.0980147256916546,0.32608695652173914,1.0,1.0,13/67,26.80%,PPP1CC;PPP3R1;MAP2K1;PPP1CA;RAP1B;MAPK1;GNAQ;NRAS;PRKACB;RPS6KA3;KRAS;RAP1A;RAF1
gsea,Salmonella infection,0.2530261429915311,1.0926838623883668,0.32558139534883723,1.0,1.0,67/249,29.90%,CSE1L;DYNC1LI1;MLKL;TUBB;GAPDH;FHOD1;MAP2K4;TUBA1B;ARPC2;HSP90B1;HSP90AA1;NCKAP1;KPNA4;MAP2K1;KIF5B;ROCK2;PFN2;SNX9;PIK3CB;DYNC1I2;TUBB4B;WASL;ACTR2;DNM2;TUBA4A;ACTR3;VPS33A;PIK3C3;PFN1;RHOA;HSP90AB1;MAPK1;VPS16;ARPC3;PODXL;TCF7;EXOC2;PIK3C2A;GCC2;KPNA1;KPNA3;ARPC1A;MAPK12;TUBB2A;RIPK2;SKP1;DCTN6;CYCS;TXN;RAB7A;MAPK8;RAB5C;CYFIP1;M6PR;SNX18;RAF1;VPS41;FLNB;FLNA;PIK3CA;DCTN4;TNFRSF10A;RAB5B;ANXA2;RAB5A;ACBD3;CHUK
gsea,Circadian rhythm,0.36626562957510567,1.0853255347387953,0.35555555555555557,1.0,1.0,6/31,23.86%,CSNK1E;CRY1;PRKAA1;CREB1;SKP1;CUL1
gsea,Amphetamine addiction,0.35249988060224796,1.081730881803385,0.32558139534883723,1.0,1.0,7/69,21.29%,PPP1CC;PPP3R1;PPP1CA;GNAS;PRKACB;HDAC2;CREB1
gsea,Nicotinate and nicotinamide metabolism,0.3471435262977363,1.0788554962387427,0.3191489361702128,1.0,1.0,3/35,13.26%,NNT;PNP;NAPRT
gsea,Signaling pathways regulating pluripotency of stem cells,-0.28556195556309105,-1.0737447880399065,0.35555555555555557,1.0,1.0,25/143,24.88%,REST;ENST00000634790.2;PIK3CD;MAPK3;JARID2;WNT5A;SKIL;DVL2;MAP2K2;MAPK13;MAPK14;ZFHX3;DVL1;MAPK11;AKT2;MYC;SMAD4;FZD7;SETDB1;PCGF1;DVL3;WNT5B;GRB2;FZD2;WNT6
gsea,Antigen processing and presentation,0.33405723381428987,1.0707492145463993,0.32653061224489793,1.0,1.0,8/78,21.29%,HSPA8;HSP90AA1;HSPA4;HSPA5;LGMN;HSP90AB1;PSME1;CREB1
gsea,Propanoate metabolism,0.42374157575446375,1.0677734667880463,0.425531914893617,1.0,1.0,10/34,30.82%,ACAT2;LDHA;HADHA;LDHB;SUCLG1;ACACA;DLD;ACAT1;MMUT;ECHDC1
gsea,Diabetic cardiomyopathy,-0.2624010995610347,-1.0660549440372635,0.3902439024390244,1.0,1.0,36/203,16.83%,UQCR11;NDUFA1;NDUFA2;NDUFB10;NDUFA13;NDUFA10;ATP5MC2;COX5B;PIK3CD;ATP5F1E;COX7C;ATP2A2;UQCRH;NDUFS7;UQCR10;COX6C;COX4I1;NDUFB4;NDUFS4;NDUFB7;NDUFA11;UQCRB;NDUFC2-KCTD14;NDUFA8;ATP5PB;SDHC;SLC25A6;MAPK13;MAPK14;NDUFB9;UQCRC1;PDHB;MPC2;MAPK11;AKT2;PRKCZ
gsea,Pancreatic secretion,0.3867584206507984,1.0527087815006657,0.39622641509433965,1.0,1.0,11/102,21.12%,RAB8A;ATP1B3;RAP1B;ADCY3;ATP1B1;PLA2G12A;RHOA;GNAQ;GNAS;ATP1A1;RAB11A
gsea,Hedgehog signaling pathway,-0.3168651706834985,-1.0523499282343673,0.37735849056603776,1.0,1.0,8/56,16.62%,CUL3;PTCH1;CSNK1G2;ARRB2;MGRN1;CSNK1D;MEGF8;ARRB1
gsea,Vasopressin-regulated water reabsorption,0.3053106073256702,1.0517220806758336,0.4222222222222222,1.0,1.0,13/44,31.37%,DYNC1LI1;DYNC1I2;ADCY3;GNAS;PRKACB;RAB11A;CREB1;DCTN6;RAB5C;DCTN4;RAB5B;RAB5A;NSF
gsea,Morphine addiction,0.292815939318355,1.04365371837184,0.36538461538461536,1.0,1.0,8/91,23.07%,PDE8A;GRK6;ADCY3;GNG12;GNAS;GNB4;PRKACB;PDE2A
gsea,Regulation of lipolysis in adipocytes,-0.3156055542907176,-1.0435894591932355,0.35294117647058826,1.0,1.0,7/55,17.38%,PIK3CD;ABHD5;PNPLA2;IRS2;AKT2;PTGS2;ADCY6
gsea,Glycosaminoglycan biosynthesis,-0.30179097335967486,-1.0433979804254587,0.3953488372093023,1.0,1.0,10/53,19.48%,DSE;NDST2;NDST1;CHPF;B3GAT3;CHPF2;ST3GAL1;B4GALT7;B3GALT6;B4GALT3
gsea,Measles,0.27000672339802806,1.0420334943387588,0.43137254901960786,1.0,1.0,27/139,31.46%,CDK2;OAS3;HSPA8;EIF2AK4;CCND3;MSN;CDK6;JAK1;PIK3CB;TBK1;STAT1;EIF2S1;STAT5B;EIF2AK2;BID;IFNAR1;CYCS;GSK3B;MAPK8;CCNE1;TNFAIP3;CD46;PIK3CA;CHUK;EIF2AK1;ADAR;CDK4
gsea,Renal cell carcinoma,0.26988618414792204,1.0418660363456638,0.3076923076923077,1.0,1.0,23/69,27.91%,FH;MAP2K1;SOS1;PIK3CB;RAP1B;PTPN11;CRK;ELOC;ELOB;MAPK1;CUL2;ARNT;NRAS;VEGFA;EPAS1;HIF1A;KRAS;CRKL;PAK2;RAP1A;SLC2A1;RAF1;PIK3CA
gsea,Prostate cancer,0.27970442179944166,1.0383557882959191,0.43137254901960786,1.0,1.0,21/97,27.91%,CDK2;E2F1;HSP90B1;HSP90AA1;MAP2K1;SOS1;PIK3CB;HSP90AB1;MAPK1;RB1;TCF7;NRAS;E2F3;CREB1;PDPK1;GSK3B;KRAS;MTOR;CCNE1;RAF1;PIK3CA
gsea,Starch and sucrose metabolism,0.45626049768187776,1.036813931004858,0.45098039215686275,1.0,1.0,5/36,17.67%,HKDC1;GPI;PGM2;PGM1;AGL
gsea,Hypertrophic cardiomyopathy,-0.32786898981408436,-1.0353748051822178,0.5319148936170213,1.0,1.0,9/90,17.50%,LMNA;ATP2A2;TPM1;ACTG1;PRKAG1;CACNB3;DAG1;TNNC1;IL6
gsea,AMPK signaling pathway,0.24884478043337988,1.029995312647359,0.3333333333333333,1.0,1.0,35/120,36.86%,ENST00000645126.2;RAB8A;PPP2CA;PPP2R1B;PIK3CB;RAB14;STRADB;PPP2R5A;FASN;ELAVL1;SCD;PRKAA1;ACACA;CREB1;PDPK1;CAB39;MTOR;RPS6KB2;CAMKK2;ADIPOR1;RPTOR;PIK3CA;PPP2R3A;SCD5;PPP2R2C;PFKFB3;PPP2CB;PFKL;RPS6KB1;MAP3K7;GYS1;RAB2A;PPARG;FBP1;PRKAB1
gsea,Melanoma,-0.2933402006997904,-1.0290316522699814,0.45454545454545453,1.0,1.0,13/72,16.72%,GADD45A;PIK3CD;MAPK3;EGFR;BAX;CDKN2A;GADD45B;PDGFC;MAP2K2;BAK1;PDGFB;AKT2;BAD
gsea,Steroid biosynthesis,0.505618591181665,1.0271937519999854,0.4791666666666667,1.0,1.0,9/20,19.96%,HSD17B7;LBR;CYP51A1;SOAT1;SQLE;MSMO1;DHCR7;SC5D;DHCR24
gsea,Glyoxylate and dicarboxylate metabolism,0.42864303981870217,1.0263592769128171,0.5,1.0,1.0,11/30,33.13%,ACAT2;GCSH;SHMT1;PGP;ACO1;MDH1;DLD;ACAT1;CS;MMUT;GLUL
gsea,TNF signaling pathway,-0.28228373180415367,-1.0254141565516701,0.3877551020408163,1.0,1.0,28/112,26.70%,TRADD;MMP14;PIK3CD;MAPK3;JUNB;CFLAR;PGAM5;TAB1;ATF6B;TAB2;CEBPB;MAPK13;MAPK14;CSF1;MAPK11;AKT2;PTGS2;IL6;BCL3;RIPK1;DAB2IP;TRAF2;NFKBIA;FADD;TAB3;CASP3;IRF1;ICAM1
gsea,Drug metabolism,0.26110495026829655,1.0216853053828718,0.36363636363636365,1.0,1.0,16/108,33.30%,RRM1;HPRT1;DPYD;NME1;DUT;UMPS;TK1;CMPK1;GMPS;UGT1A3;TPMT;MGST1;RRM2;UGT1A1;UCK2;UCK1
gsea,Cytosolic DNA-sensing pathway,-0.3218413900389778,-1.0164139547774544,0.4807692307692308,1.0,1.0,15/63,27.93%,POLR1D;PYCARD;POLR2F;POLR3A;POLR3GL;TREX1;IL6;POLR1C;RIPK1;MAVS;POLR3C;NFKBIA;IL18;POLR3H;POLR3B
gsea,Endometrial cancer,-0.27412447378954274,-1.0140017724463384,0.36363636363636365,1.0,1.0,12/58,17.05%,GADD45A;PIK3CD;MAPK3;EGFR;ERBB2;BAX;GADD45B;MAP2K2;BAK1;AKT2;BAD;MYC
gsea,HIF-1 signaling pathway,0.2780437721019497,1.0050996586897722,0.44680851063829785,1.0,1.0,26/109,25.88%,GAPDH;ALDOA;EIF4E;TFRC;HKDC1;MAP2K1;LDHA;PGK1;PIK3CB;PDHA1;MKNK2;ELOC;ENO1;ELOB;LDHB;MAPK1;CUL2;ARNT;VEGFA;HIF1A;ENO2;MTOR;RPS6KB2;SLC2A1;TIMP1;HMOX1
gsea,Central carbon metabolism in cancer,0.29265965628392643,1.0047593244429518,0.44642857142857145,1.0,1.0,20/70,28.80%,SLC7A5;HKDC1;MAP2K1;LDHA;GLS;PIK3CB;PDHA1;SLC1A5;LDHB;MAPK1;NRAS;PKM;HIF1A;PGAM1;KRAS;MTOR;SLC2A1;RAF1;PIK3CA;IDH1
gsea,Pathways in cancer,0.21754334646012202,1.0039618276975881,0.4117647058823529,1.0,1.0,81/531,25.88%,CDK2;E2F1;HSP90B1;HSP90AA1;FN1;MSH2;CTBP2;FH;CCND3;MAP2K1;ROCK2;CDK6;STK4;SOS1;JAK1;PIK3CB;TPR;DDB2;APPL1;CCDC6;KITLG;STAT1;RALB;ADCY3;CRK;RAD51;GNG12;ELOC;LAMC1;ELOB;BIRC5;RHOA;HSP90AB1;STAT5B;MAPK1;GNAQ;RB1;GNAS;CKS1B;IL13RA1;CUL2;EML4;ITGB1;ROCK1;ARNT;TCF7;ITGA6;NRAS;RUNX1;ITGA3;IL4R;GNB4;BMP4;NOTCH1;PRKACB;HDAC2;VEGFA;E2F3;EPAS1;HIF1A;BID;TFG;CDH1;IFNAR1;SKP1;NFE2L2;CYCS;GSK3B;KRAS;RASGRP1;MAPK8;CRKL;PPARD;CUL1;MTOR;LAMA5;RPS6KB2;LAMA3;CCNE1;SLC2A1;HMOX1
gsea,Ether lipid metabolism,0.36495931840983176,0.9983693626008968,0.4782608695652174,1.0,1.0,10/49,31.87%,SELENOI;LPCAT4;PLPP1;PLA2G12A;CHPT1;CEPT1;PAFAH1B1;AGPS;LPCAT2;PAFAH1B2
gsea,"Glycine, serine and threonine metabolism",0.38256820289119003,0.9959961496465604,0.48214285714285715,1.0,1.0,8/40,33.83%,PSAT1;GCSH;SHMT1;PHGDH;PGAM1;DLD;ALAS1;PSPH
gsea,Necroptosis,0.24126865967949307,0.989486375468114,0.4782608695652174,1.0,1.0,23/159,24.18%,SLC25A5;MLKL;CHMP2B;HMGB1;HSP90AA1;CYLD;PARP1;VDAC3;DNM1L;JAK1;VPS4B;STAT1;SMPD1;HSP90AB1;STAT5B;CHMP4C;EIF2AK2;FAF1;BID;IFNAR1;TRPM7;MAPK8;AIFM1
gsea,Galactose metabolism,0.34898625814072914,0.9795635456905772,0.4423076923076923,1.0,1.0,13/31,41.50%,HKDC1;PGM2;PGM1;GALE;GLA;PFKL;HK2;AKR1B10;B4GALT1;B4GALT2;UGP2;G6PC3;GALM
gsea,Fatty acid degradation,0.3033492491404919,0.975817874816595,0.4,1.0,1.0,6/43,16.38%,ACAT2;ACSL3;HADHA;HADH;ALDH2;ALDH9A1
gsea,Various types of N-glycan biosynthesis,0.2992337788093763,0.9695961453806332,0.5106382978723404,1.0,1.0,15/39,36.49%,MAN2A1;RPN2;ALG3;MGAT1;RPN1;ALG11;HEXB;MAN1A1;STT3A;ALG13;B4GALT1;B4GALT2;ALG2;FUT8;MAN1A2
gsea,Alcoholism,0.2591127572933048,0.9687636801183257,0.48,1.0,1.0,17/186,26.80%,PPP1CC;MAP2K1;SOS1;PPP1CA;HDAC3;GNG12;ADORA2B;MAPK1;GNAS;NRAS;GNB4;PRKACB;HDAC2;CREB1;KRAS;CAMKK2;RAF1
gsea,Carbohydrate digestion and absorption,0.3571697933952433,0.9630049522629992,0.5098039215686274,1.0,1.0,5/47,19.11%,ATP1B3;HKDC1;PIK3CB;ATP1B1;ATP1A1
gsea,Vascular smooth muscle contraction,0.261695030209921,0.9593979341853475,0.5423728813559322,1.0,1.0,15/133,20.31%,PPP1CC;MYH14;MAP2K1;ROCK2;PPP1CA;ADCY3;ADORA2B;PLA2G12A;RHOA;MAPK1;GNAQ;GNAS;ROCK1;PRKACB;PPP1R12A
gsea,Mucin type O-glycan biosynthesis,0.37967956766515787,0.9591566477999104,0.45454545454545453,1.0,1.0,8/36,32.38%,GALNT2;GALNT7;GALNT3;GALNT14;GALNT12;GALNT6;GALNT10;C1GALT1C1
gsea,Insulin signaling pathway,0.23631515802310668,0.956174242069135,0.6,1.0,1.0,28/137,27.91%,PPP1CC;PRKCI;EIF4E;HKDC1;MAP2K1;SOS1;PPP1CA;PIK3CB;MKNK2;FASN;CRK;MAPK1;NRAS;PRKACB;PRKAA1;ACACA;PRKAR2A;PDPK1;GSK3B;KRAS;MAPK8;CRKL;MTOR;RPS6KB2;RAF1;INPP5A;RPTOR;PIK3CA
gsea,Hepatitis B,0.24324038599815623,0.9553761734457626,0.5769230769230769,1.0,1.0,27/162,23.39%,CDK2;PCNA;E2F1;MAP2K4;VDAC3;MAP2K1;SOS1;JAK1;PIK3CB;DDB2;YWHAZ;TBK1;STAT1;BIRC5;STAT5B;MAPK1;RB1;NRAS;E2F3;YWHAB;MAPK12;BID;CREB1;IFNAR1;CYCS;KRAS;MAPK8
gsea,Endocrine and other factor-regulated calcium reabsorption,0.312156341460945,0.9529348443354198,0.4423076923076923,1.0,1.0,10/53,22.83%,ATP1B3;DNM2;ATP1B1;GNAQ;GNAS;PRKACB;ATP1A1;RAB11A;DNM1;AP2B1
gsea,Glutamatergic synapse,0.26506876274244323,0.9488435750694159,0.5892857142857143,1.0,1.0,9/114,18.71%,PPP3R1;GLS;ADCY3;GNG12;MAPK1;GNAQ;GNAS;GNB4;PRKACB
gsea,"Growth hormone synthesis, secretion and action",0.2243921802815413,0.9458235072629958,0.5964912280701754,1.0,1.0,20/119,24.04%,MAP2K4;MAP2K1;SOS1;PIK3CB;STAT1;ADCY3;CRK;STAT5B;MAPK1;GNAQ;GNAS;NRAS;PRKACB;MAPK12;CREB1;GSK3B;KRAS;MAPK8;CRKL;MTOR
gsea,Epstein-Barr virus infection,0.23780760680703,0.9425486941558961,0.5892857142857143,1.0,1.0,32/202,23.39%,CDK2;E2F1;MAP2K4;OAS3;PSMD14;PSMD6;SIN3A;PSMD1;CCND3;CD58;CDK6;PSMD11;JAK1;PIK3CB;DDB2;PSMD7;TBK1;ENST00000629691.2;STAT1;PSMC6;RB1;EIF2AK2;HDAC2;E2F3;SNW1;MAPK12;BID;PSMC3;IFNAR1;RBPJ;CYCS;MAPK8
gsea,Chemokine signaling pathway,0.23648376999136927,0.940960788069829,0.5217391304347826,1.0,1.0,18/192,18.71%,MAP2K1;ROCK2;SOS1;GRK6;PIK3CB;RAP1B;STAT1;ADCY3;CRK;GNG12;RHOA;STAT5B;MAPK1;GNAQ;ROCK1;NRAS;GNB4;PRKACB
gsea,Bile secretion,0.3780652743145656,0.9408738176357491,0.6346153846153846,1.0,1.0,11/90,25.71%,ABCC2;ATP1B3;NCEH1;LDLR;ADCY3;ATP1B1;GNAS;PRKACB;ATP1A1;UGT1A3;SLC2A1
gsea,Glycerophospholipid metabolism,0.2628111148419528,0.937524343826383,0.5294117647058824,1.0,1.0,17/98,23.06%,LPIN1;PEMT;GNPAT;PNPLA6;SELENOI;LPGAT1;PTDSS1;LPCAT4;PLPP1;PLA2G12A;CHPT1;CDS1;CEPT1;GPD2;DGKG;LPCAT3;MBOAT2
gsea,Alzheimer disease,-0.20549830797012802,-0.9306314645741675,0.5416666666666666,1.0,1.0,81/369,25.27%,APH1A;UQCR11;NDUFA1;NDUFA2;NDUFB10;NDUFA13;ATG101;DKK1;KLC2;NDUFA10;ATP5MC2;COX5B;PIK3CD;MAPK3;ATP5F1E;BACE2;APP;COX7C;ATP2A2;ATG2A;KLC3;WNT5A;CAPN1;UQCRH;DVL2;NDUFS7;UQCR10;COX6C;COX4I1;IRS2;NDUFB4;FRAT2;PSMB5;NDUFS4;NDUFB7;NDUFA11;UQCRB;ATG13;NDUFC2-KCTD14;MAP2K2;NDUFA8;ATP5PB;SDHC;SLC25A6;CDK5;NDUFB9;UQCRC1;DVL1;CSF1;AKT2;BAD;PTGS2;IL6;ATG14;NDUFS3;FZD7;DDIT3;NDUFC2;TRAF2;COX7B2;DVL3;UQCRQ;NDUFB2;PSMD2;WNT5B;NDUFB1;SNCA;CALM3;SDHD;NDUFB8;COX7A2;WIPI2;FADD;PSMD9;PPP3CA;NDUFB3;NDUFS5;FZD2;WNT6;CSNK2A2;CASP3
gsea,Lipid and atherosclerosis,0.22649922558257563,0.928481553217527,0.5283018867924528,1.0,1.0,28/215,23.39%,MAP2K4;HSPD1;HSP90B1;HSPA8;HSP90AA1;PPP3R1;HSPA4;ROCK2;PIK3CB;RAP1B;HSPA5;TBK1;LDLR;EIF2S1;RHOA;HSP90AB1;MAPK1;NRAS;XBP1;MAPK12;BID;PDPK1;ERO1A;NFE2L2;CYCS;GSK3B;KRAS;MAPK8
gsea,Sphingolipid signaling pathway,0.21887400965330917,0.9270775031223372,0.54,1.0,1.0,31/119,31.81%,MAP2K1;ROCK2;NSMAF;PPP2CA;PPP2R1B;PIK3CB;CERS2;CERS6;PPP2R5A;SPTLC1;SMPD1;RHOA;MAPK1;GNAQ;ROCK1;NRAS;S1PR3;MAPK12;BID;PDPK1;KRAS;MAPK8;SPTLC2;RAF1;PIK3CA;CERS5;PPP2R3A;PPP2R2C;SPHK1;PPP2CB;SGMS1
gsea,Osteoclast differentiation,-0.2401330199402855,-0.9168432841818821,0.66,1.0,1.0,21/127,25.57%,RELB;PIK3CD;MAPK3;JUND;JUNB;TAB1;FHL2;TAB2;STAT2;MAPK13;MAPK14;CSF1;MAPK11;AKT2;TRAF2;NFKB2;GAB2;GRB2;NFKBIA;PPP3CA;SIRPA
gsea,cGMP-PKG signaling pathway,0.2559176637321284,0.9158775013036592,0.5882352941176471,1.0,1.0,17/167,21.29%,SLC25A5;PPP1CC;PPP3R1;ATP1B3;VDAC3;MAP2K1;ROCK2;PPP1CA;ADCY3;ATP1B1;RHOA;MAPK1;GNAQ;ROCK1;ATP1A1;PPP1R12A;CREB1
gsea,Chronic myeloid leukemia,0.2485570334714837,0.9088922594225876,0.5192307692307693,1.0,1.0,16/76,19.48%,E2F1;CTBP2;MAP2K1;CDK6;SOS1;PIK3CB;DDB2;PTPN11;CRK;STAT5B;MAPK1;RB1;NRAS;RUNX1;HDAC2;E2F3
gsea,Leukocyte transendothelial migration,-0.23205412316396684,-0.903590710401357,0.6,1.0,1.0,28/114,29.44%,CD99L2;MYLPF;PIK3CD;BCAR1;ACTG1;VASP;CD99;PTK2B;CLDN4;MAPK13;MAPK14;CLDN7;CLDN23;AFDN;MAPK11;PXN;ITGAM;MYL5;PRKCG;MYL12B;ARHGAP35;MYL9;ICAM1;CTNNB1;CLDN3;CLDN9;RAC2;PLCG1
gsea,Endocytosis,0.20216025250908803,0.9027277641374598,0.6585365853658537,1.0,1.0,46/252,23.75%,ARPC2;CHMP2B;HSPA8;VPS37A;PRKCI;VTA1;RAB8A;TFRC;CAPZA1;KIF5B;EHD4;GRK6;STAMBP;WASL;VPS4B;USP8;ACTR2;VPS35;DNM2;VPS26A;GBF1;IQSEC1;ACTR3;LDLR;PDCD6IP;VPS25;PIP5K1A;RABEP1;RHOA;SNX1;VPS36;ARPC3;RAB35;CHMP4C;ACAP2;STAM;SMAP1;ARPC1A;VPS45;RAB11A;DNM1;AP2B1;WASHC4;RAB7A;CAPZA2;RAB5C
gsea,Wnt signaling pathway,0.21240695342993737,0.900553461247019,0.6458333333333334,1.0,1.0,21/166,24.41%,RYK;PPP3R1;CTBP2;CCND3;ROCK2;VANGL1;CSNK1E;DAAM1;RHOA;TCF7;TBL1XR1;PRKACB;CACYBP;SFRP1;SKP1;GSK3B;CTNNBIP1;MAPK8;PPARD;CUL1;NLK
gsea,p53 signaling pathway,0.25300042731017824,0.8990698239688777,0.5740740740740741,1.0,1.0,16/73,25.67%,CDK2;CHEK1;CDK1;GTSE1;CCND3;CCNB2;CDK6;DDB2;CCNB1;SERPINB5;BID;COP1;CYCS;ATR;CCNE1;SFN
gsea,RNA polymerase,-0.23492857048120871,-0.8970526057444435,0.6956521739130435,1.0,1.0,12/31,31.15%,POLR1D;POLR2F;POLR3A;POLR3GL;POLR2A;POLR2G;POLR1C;POLR3C;POLR3H;POLR3B;POLR2J;POLR2D
gsea,N-Glycan biosynthesis,0.257734865734666,0.8927308656721944,0.5384615384615384,1.0,1.0,18/50,36.49%,MAN2A1;DPM2;RPN2;ALG3;MGAT1;RPN1;ALG11;MAN1A1;STT3A;DPAGT1;MOGS;ALG13;ALG8;B4GALT1;B4GALT2;ALG2;FUT8;MAN1A2
gsea,Aldosterone-regulated sodium reabsorption,-0.26626313341597396,-0.8895877907536478,0.625,1.0,1.0,4/37,7.62%,SCNN1A;PIK3CD;MAPK3;SLC9A3R2
gsea,PPAR signaling pathway,0.26719013283947696,0.8861458839225589,0.6545454545454545,1.0,1.0,17/74,39.09%,ME1;ACSL3;FABP5;HMGCS1;SCD;PDPK1;PPARD;ACADM;PPARA;SCD5;SLC27A4;ACSL5;FADS2;PPARG;ACOX3;ACSL4;ACSL1
gsea,TGF-beta signaling pathway,-0.23036290237048254,-0.8844776508562385,0.7021276595744681,1.0,1.0,8/94,12.93%,ENST00000634790.2;CDKN2B;MAPK3;BAMBI;THSD4;SMAD7;THBS1;TFDP1
gsea,Long-term depression,0.29909783721198113,0.8819097972176424,0.7021276595744681,1.0,1.0,7/60,18.15%,MAP2K1;PPP2CA;PPP2R1B;MAPK1;GNAQ;GNAS;NRAS
gsea,Viral carcinogenesis,0.20019594241445485,0.8807769882146037,0.66,1.0,1.0,34/203,26.18%,CDK2;YWHAE;CHEK1;CDK1;YWHAH;VDAC3;CCND3;CDK6;JAK1;PIK3CB;HDAC3;GTF2H1;UBR4;YWHAZ;RHOA;STAT5B;MAPK1;RB1;NRAS;PRKACB;EIF2AK2;HDAC2;YWHAB;SNW1;CDC20;PKM;CREB1;RANBP1;RBPJ;KRAS;GTF2E2;YWHAQ;CCNE1;MRPS18B
gsea,Hepatocellular carcinoma,-0.2296820501951572,-0.8793814238229978,0.6590909090909091,1.0,1.0,33/168,24.88%,GADD45A;PIK3CD;MAPK3;EGFR;WNT5A;ACTL6A;BAX;DVL2;ACTG1;SMARCC1;FRAT2;CDKN2A;GADD45B;MGST2;MGST3;MAP2K2;BAK1;DVL1;AKT2;BAD;SMARCA4;MYC;SMAD4;FZD7;DVL3;WNT5B;PRKCG;GRB2;GSTP1;SMARCD2;NQO1;FZD2;WNT6
gsea,Cytokine-cytokine receptor interaction,-0.26339885222850984,-0.8793145388711641,0.6744186046511628,1.0,1.0,13/295,22.06%,LTBR;TNFRSF12A;INHA;GDF15;CD27;IL32;CSF1;CTF1;IL23A;IL6;TNFRSF21;TNFRSF10B;CLCF1
gsea,Glycosphingolipid biosynthesis,0.27639212938621566,0.8766407113400025,0.5714285714285714,1.0,1.0,5/45,21.38%,B3GNT5;B3GNT2;GLA;SLC33A1;HEXB
gsea,Thyroid cancer,0.23754839135582154,0.8759480766159286,0.66,1.0,1.0,10/37,23.29%,MAP2K1;TPR;DDB2;CCDC6;MAPK1;TCF7;NRAS;TFG;CDH1;KRAS
gsea,Steroid hormone biosynthesis,0.32796694366115225,0.8711054411978443,0.5957446808510638,1.0,1.0,5/61,22.39%,HSD17B12;HSD17B7;AKR1C2;UGT1A3;SULT2B1
gsea,Th17 cell differentiation,0.25411063245190607,0.8696564611752817,0.6190476190476191,1.0,1.0,14/107,24.04%,HSP90AA1;PPP3R1;JAK1;STAT1;HSP90AB1;STAT5B;MAPK1;RNA5SP498;RUNX1;IL4R;MAPK12;HIF1A;MAPK8;MTOR
gsea,Cholinergic synapse,0.2393788281126663,0.8684486576827017,0.7647058823529411,1.0,1.0,11/113,23.29%,MAP2K1;PIK3CB;ADCY3;GNG12;MAPK1;GNAQ;NRAS;GNB4;PRKACB;CREB1;KRAS
gsea,Phagosome,0.2567937633105271,0.8670292618866198,0.62,1.0,1.0,35/152,37.76%,DYNC1LI1;TUBB;TUBA1B;TFRC;DYNC1I2;TUBB4B;TUBA4A;ATP6V1C1;PIK3C3;SEC61G;ATP6V0E2;ITGB1;TUBB2A;ATP6V0E1;RAB7A;RAB5C;CANX;M6PR;ATP6V0A1;ITGA5;RAB5B;RAB5A;NCF2;ACTB;HLA-B;VAMP3;STX7;ATP6V1E1;ATP6V1D;SEC22B;ATP6V1A;SEC61B;DYNC1H1;RAC1;SEC61A1
gsea,MAPK signaling pathway,-0.21186677751344188,-0.8654764576971874,0.7254901960784313,1.0,1.0,46/294,24.62%,GADD45A;TRADD;RAPGEF2;RELB;MAPK3;JUND;MAPKAPK2;TAOK2;EGFR;NFATC3;ERBB2;EFNA4;TAB1;RRAS;NTF4;MAP3K11;SRF;DUSP1;MAPK8IP3;GADD45B;PDGFC;MAP2K2;TAB2;CACNB3;MAPK13;ARRB2;MAPK14;PDGFB;CSF1;MAPK11;AKT2;ARRB1;MYC;MAP4K4;DUSP3;DDIT3;RASA1;EFNA1;TRAF2;NFKB2;PRKCG;RASGRF1;GRB2;CDC25B;PPP3CA;ECSIT
gsea,Bacterial invasion of epithelial cells,0.25479078704430674,0.8601920549716471,0.5652173913043478,1.0,1.0,20/77,28.22%,ARPC2;FN1;PIK3CB;WASL;ACTR2;DNM2;ACTR3;VCL;CRK;RHOA;ARPC3;ITGB1;CD2AP;ARPC1A;DNM1;CDH1;CRKL;PIK3CA;ITGA5;ARHGAP10
gsea,Human immunodeficiency virus 1 infection,0.20685842828151266,0.8580756773850288,0.6829268292682927,1.0,1.0,36/212,24.50%,DCAF1;CHEK1;CDK1;PPP3R1;MAP2K1;AP1S2;CCNB2;AP1S3;PIK3CB;CDC25C;TBK1;CRK;AP1B1;GNG12;ELOC;ELOB;CCNB1;MAPK1;GNAQ;NRAS;GNB4;CUL5;AP1G1;MAPK12;APOBEC3B;BID;SKP1;CYCS;KRAS;MAPK8;CRKL;CUL1;MTOR;PAK2;CUL4B;ATR
gsea,Cortisol synthesis and secretion,0.27494420994387114,0.858040072483783,0.6346153846153846,1.0,1.0,8/65,21.29%,PDE8A;NCEH1;LDLR;ADCY3;GNAQ;GNAS;PRKACB;CREB1
gsea,Yersinia infection,0.20272793260326688,0.8572921555775737,0.7,1.0,1.0,25/137,23.69%,MAP2K4;ARPC2;FN1;MAP2K1;ROCK2;PIK3CB;WASL;ACTR2;TBK1;ACTR3;BAIAP2;CRK;PIP5K1A;RHOA;MAPK1;GNAQ;ARPC3;ITGB1;ROCK1;ARPC1A;MAPK12;RPS6KA3;GSK3B;MAPK8;CRKL
gsea,RIG-I-like receptor signaling pathway,-0.27251314002404425,-0.8540489402209351,0.6666666666666666,1.0,1.0,11/70,23.91%,TRADD;TKFC;MAPK13;MAPK14;MAPK11;OTUD5;RIPK1;TRAF2;MAVS;NFKBIA;FADD
gsea,Platelet activation,0.21807847313357623,0.8434161806798466,0.7,1.0,1.0,16/124,20.54%,PPP1CC;PRKCI;ROCK2;PPP1CA;PIK3CB;RAP1B;ADCY3;RHOA;MAPK1;GNAQ;GNAS;ITGB1;ROCK1;PRKACB;PPP1R12A;MAPK12
gsea,C-type lectin receptor signaling pathway,-0.2409966846587621,-0.842284826024232,0.6666666666666666,1.0,1.0,22/104,24.33%,RELB;PIK3CD;MAPK3;MAPKAPK2;PYCARD;NFATC3;RRAS;STAT2;MAPK13;MAPK14;MAPK11;AKT2;IL23A;PTGS2;IL6;BCL3;ARHGEF12;NFKB2;CALM3;PLK3;NFKBIA;PPP3CA
gsea,Focal adhesion,0.20715222629560073,0.8380704181848443,0.7142857142857143,1.0,1.0,38/201,28.16%,ARHGAP5;FN1;PPP1CC;CCND3;MAP2K1;ROCK2;SOS1;PPP1CA;PIK3CB;DIAPH1;RAP1B;VCL;CRK;PIP5K1A;LAMC1;RHOA;MAPK1;ITGB1;ROCK1;ITGA6;ITGA3;VEGFA;ITGB4;PPP1R12A;PDPK1;GSK3B;MAPK8;CRKL;PAK2;LAMA5;RAP1A;LAMA3;SPP1;RAF1;FLNB;FLNA;PIK3CA;ITGA5
gsea,Ovarian steroidogenesis,0.3291181167786591,0.8378230919715804,0.7115384615384616,1.0,1.0,5/51,18.71%,HSD17B7;LDLR;ADCY3;GNAS;PRKACB
gsea,Estrogen signaling pathway,0.24626149381257467,0.8339007078474111,0.75,1.0,1.0,13/137,18.71%,HSP90B1;HSPA8;HSP90AA1;MAP2K1;SOS1;PIK3CB;ADCY3;HSP90AB1;MAPK1;GNAQ;GNAS;NRAS;PRKACB
gsea,Toll-like receptor signaling pathway,-0.23716980156023426,-0.8338790937041667,0.6041666666666666,1.0,1.0,13/104,19.57%,TICAM1;TOLLIP;PIK3CD;MAPK3;TAB1;MAP2K2;TAB2;MAPK13;MAPK14;MAPK11;AKT2;IL6;RIPK1
gsea,Amoebiasis,0.22912711374049127,0.8297387259960631,0.7192982456140351,1.0,1.0,19/102,33.53%,FN1;PRDX1;PIK3CB;ARG2;VCL;LAMC1;GNAQ;GNAS;PRKACB;RAB7A;RAB5C;LAMA5;LAMA3;PIK3CA;RAB5B;RAB5A;PTK2;LAMC2;IL1R2
gsea,Fc gamma R-mediated phagocytosis,-0.22332137584969353,-0.8215964116036003,0.8,1.0,1.0,7/97,6.94%,MARCKSL1;GSN;PLD2;PIK3CD;MAPK3;ARPC5;MARCKS
gsea,Non-small cell lung cancer,0.2396584031518738,0.819934117929421,0.8076923076923077,1.0,1.0,15/72,21.33%,E2F1;MAP2K1;KIF5B;CDK6;STK4;SOS1;PIK3CB;DDB2;STAT5B;MAPK1;RB1;EML4;NRAS;E2F3;PDPK1
gsea,Gastric cancer,-0.21250027755133136,-0.8197433827110508,0.7380952380952381,1.0,1.0,18/149,18.13%,GADD45A;CDKN2B;PIK3CD;MAPK3;EGFR;WNT5A;ERBB2;BAX;DVL2;JUP;FRAT2;GADD45B;MAP2K2;BAK1;DVL1;AKT2;MYC;SMAD4
gsea,Peroxisome,0.2947963708270165,0.8196521080613688,0.7222222222222222,1.0,1.0,9/82,9.87%,FAR1;PXMP2;GNPAT;ABCD3;ACSL3;DECR2;AMACR;PRDX1;PEX19
gsea,Pathways of neurodegeneration,-0.17813380238234727,-0.8182054274950695,0.74,1.0,1.0,99/475,24.99%,UQCR11;NDUFA1;DNAL4;NDUFA2;NDUFB10;NDUFA13;ATG101;DKK1;KLC2;NDUFA10;CCS;ATP5MC2;COX5B;MAPK3;ATP5F1E;APP;COX7C;ATP2A2;CAT;ATG2A;RAB1A;KLC3;WNT5A;ZFYVE1;CAPN1;UQCRH;BAX;DVL2;NDUFS7;UQCR10;COX6C;COX4I1;NDUFB4;FRAT2;PSMB5;NDUFS4;NDUFB7;NDUFA11;UQCRB;ATXN2L;ATG13;NDUFC2-KCTD14;MAP2K2;NDUFA8;ATP5PB;SDHC;GABARAPL1;SLC25A6;MAPK13;MAPK14;CDK5;NDUFB9;BAK1;UQCRC1;DVL1;CSF1;MAPK11;BAD;UBB;PTGS2;IL6;UBC;ATG14;NDUFS3;PINK1;GABARAP;FZD7;DDIT3;NDUFC2;TRAF2;DCTN1;COX7B2;DVL3;UQCRQ;NDUFB2;UBE2L6;PSMD2;WNT5B;NDUFB1;PRKCG;SNCA;CALM3;SDHD;NDUFB8;ENST00000639332.2;DCTN5;DNAH11;COX7A2;WIPI2;ACTR10;FADD;PSMD9;PPP3CA;NDUFB3;NDUFS5;DERL1;FZD2;WNT6;CSNK2A2
gsea,VEGF signaling pathway,-0.21951349294833644,-0.808791618251512,0.7317073170731707,1.0,1.0,11/59,17.23%,PIK3CD;MAPK3;MAPKAPK2;MAP2K2;MAPK13;MAPK14;MAPK11;PXN;AKT2;BAD;PTGS2
gsea,Notch signaling pathway,-0.20437491918995848,-0.8086171454775605,0.8085106382978723,1.0,1.0,7/59,15.59%,APH1A;MFNG;DTX2;DVL2;NUMB;NUMBL;DVL1
gsea,Gastric acid secretion,0.2813824805355055,0.8085833959453604,0.6792452830188679,1.0,1.0,7/76,19.11%,ATP1B3;ADCY3;ATP1B1;GNAQ;GNAS;PRKACB;ATP1A1
gsea,Arachidonic acid metabolism,0.30851771245016635,0.805215211798956,0.7407407407407407,1.0,1.0,4/61,16.33%,GPX8;GPX2;PTGES3;PLA2G12A
gsea,Sphingolipid metabolism,0.30111090861965767,0.8037669069772673,0.7083333333333334,1.0,1.0,10/49,31.81%,CERS2;CERS6;PLPP1;SPTLC1;SMPD1;GLA;SPTLC2;CERS5;SPHK1;SGMS1
gsea,Other types of O-glycan biosynthesis,0.2660513699988433,0.8018589577866335,0.7727272727272727,1.0,1.0,14/47,35.36%,GALNT2;GALNT7;GALNT3;COLGALT1;XXYLT1;GALNT14;B3GLCT;POFUT1;GALNT12;GALNT6;GALNT10;C1GALT1C1;B4GALT1;B4GALT2
gsea,Influenza A,0.22681990316272066,0.797903965874327,0.8260869565217391,1.0,1.0,22/172,22.84%,SLC25A5;BCL2L2-PABPN1;OAS3;NXT2;KPNA2;XPO1;CCND3;MAP2K1;CDK6;JAK1;PIK3CB;DNAJC3;TBK1;STAT1;EIF2S1;MAPK1;EIF2AK2;KPNA1;BID;RAB11A;IFNAR1;CYCS
gsea,Bladder cancer,-0.25306482919858125,-0.7902412234918095,0.7674418604651163,1.0,1.0,9/41,17.05%,MAPK3;EGFR;ERBB2;DAPK2;CDKN2A;THBS1;MAP2K2;DAPK3;MYC
gsea,Phosphatidylinositol signaling system,0.19039764026601314,0.7878981609252443,0.8367346938775511,1.0,1.0,12/97,21.48%,PIP4K2A;PI4K2B;MTMR6;SACM1L;PIK3CB;PIK3C3;PIP5K1A;CDS1;IMPA2;PIK3C2A;PI4KA;DGKG
gsea,Dilated cardiomyopathy,-0.24834976689882138,-0.7856752536238294,0.7777777777777778,1.0,1.0,8/96,17.38%,LMNA;ATP2A2;TPM1;ACTG1;CACNB3;DAG1;TNNC1;ADCY6
gsea,Apelin signaling pathway,0.18759011897940167,0.7837216620238143,0.8076923076923077,1.0,1.0,30/137,37.89%,MAP2K1;PIK3C3;ADCY3;GNG12;TFAM;PIK3R4;MAPK1;GNAQ;NRAS;GNB4;PRKACB;PRKAA1;CDH1;KRAS;MTOR;RPS6KB2;SPP1;RAF1;NOTCH3;KLF2;SPHK1;GNG10;RPS6KB1;ITPR3;BECN1;PRKAB1;JAG1;CALM1;CALM2;GNB1
gsea,Mineral absorption,0.27275798079703684,0.7813454986577604,0.8490566037735849,1.0,1.0,12/60,33.23%,ATP1B3;SLC31A1;CYBRD1;MT1A;ATP1B1;ATP1A1;TRPM7;HMOX1;STEAP1;ATOX1;MT1E;VDR
gsea,GABAergic synapse,0.2131915741504021,0.7807534754668491,0.7962962962962963,1.0,1.0,15/89,41.99%,GLS;ADCY3;GNG12;GNB4;PRKACB;TRAK2;NSF;GNG10;GLUL;GNB1;GABRA3;GNAI2;PRKCA;GNB5;SLC38A1
gsea,Fc epsilon RI signaling pathway,0.22344205753879962,0.7799109843567573,0.8,1.0,1.0,12/68,27.91%,MAP2K4;MAP2K1;SOS1;PIK3CB;MAPK1;NRAS;MAPK12;PDPK1;KRAS;MAPK8;RAF1;PIK3CA
gsea,Oxytocin signaling pathway,0.19303925101416056,0.7752599544359638,0.9130434782608695,1.0,1.0,15/154,20.31%,PPP1CC;PPP3R1;MAP2K1;ROCK2;PPP1CA;ADCY3;RHOA;MAPK1;GNAQ;GNAS;ROCK1;NRAS;PRKACB;PRKAA1;PPP1R12A
gsea,Autophagy,-0.17986982913980956,-0.769581591594591,0.8846153846153846,1.0,1.0,28/137,20.80%,ATG101;VAMP8;PIK3CD;MAPK3;TP53INP2;ATG2A;RAB1A;ATG4B;ZFYVE1;CFLAR;AKT1S1;RRAS;IRS2;DAPK2;ATG13;RRAGB;MAP2K2;VMP1;GABARAPL1;ATG9B;DAPK3;AKT2;BAD;ATG14;GABARAP;LAMP2;RRAGA;LAMP1
gsea,Dopaminergic synapse,0.2199813689578954,0.7694668981423379,0.8222222222222222,1.0,1.0,15/132,23.39%,PPP1CC;KIF5B;PPP2CA;PPP1CA;PPP2R1B;PPP2R5A;GNG12;GNAQ;GNAS;GNB4;PRKACB;MAPK12;CREB1;GSK3B;MAPK8
gsea,Huntington disease,-0.18861641066863938,-0.7693738918929975,0.8095238095238095,1.0,1.0,38/306,13.64%,REST;UQCR11;NDUFA1;CLTB;DNAL4;NDUFA2;NDUFB10;NDUFA13;ATG101;KLC2;NDUFA10;ATP5MC2;COX5B;BBC3;ATP5F1E;COX7C;ATG2A;KLC3;AP2S1;POLR2F;UQCRH;BAX;NDUFS7;UQCR10;COX6C;COX4I1;NDUFB4;PSMB5;NDUFS4;NDUFB7;NDUFA11;UQCRB;ATG13;NDUFC2-KCTD14;NDUFA8;ATP5PB;SDHC;SLC25A6
gsea,Lysosome,-0.23746130224888812,-0.7691934023091521,0.6923076923076923,1.0,1.0,28/128,24.45%,CLTB;CD63;ACP2;CTSF;ATP6V0B;PSAP;GGA1;CLN3;SUMF1;DNASE2;GALNS;NPC2;GNPTG;CTSZ;CTSA;SLC17A5;GLB1;AP1G2;HYAL2;CTNS;LAMP2;LAMP1;PLA2G15;ARSA;ASAH1;NAGPA;CTSH;HEXA
gsea,Kaposi sarcoma-associated herpesvirus infection,0.19413849524250978,0.7680993981615465,0.8666666666666667,1.0,1.0,31/193,24.04%,E2F1;MAP2K4;ATG3;PPP3R1;MAP2K1;CDK6;JAK1;PIK3CB;TBK1;PIK3C3;STAT1;RPS27A;GNG12;MAPK1;RB1;TCF7;NRAS;GNB4;EIF2AK2;VEGFA;E2F3;MAPK12;HIF1A;BID;CREB1;IFNAR1;CYCS;GSK3B;KRAS;MAPK8;MTOR
gsea,Phospholipase D signaling pathway,-0.195953164118192,-0.7671405395128087,0.8571428571428571,1.0,1.0,16/148,17.38%,PLD2;PIK3CD;MAPK3;LPAR2;DGKZ;EGFR;CYTH1;RRAS;PDGFC;CYTH2;MAP2K2;PTK2B;PDGFB;AKT2;AGPAT2;ADCY6
gsea,Mitophagy,-0.19916517497364072,-0.7666894326621357,0.84,1.0,1.0,16/68,20.73%,TOMM7;FIS1;PGAM5;RHOT1;RRAS;GABARAPL1;RHOT2;ATG9B;USP15;UBB;UBC;PINK1;GABARAP;TFE3;CITED2;TBC1D17
gsea,Prolactin signaling pathway,0.2214911930749783,0.7637265910097782,0.8076923076923077,1.0,1.0,13/70,27.91%,MAP2K1;SOS1;PIK3CB;STAT1;STAT5B;MAPK1;NRAS;MAPK12;GSK3B;KRAS;MAPK8;RAF1;PIK3CA
gsea,Aldosterone synthesis and secretion,0.24618853651828596,0.7618425123370686,0.8103448275862069,1.0,1.0,10/98,23.07%,ATP1B3;LDLR;ADCY3;ATP1B1;GNAQ;GNAS;PRKACB;ATP1A1;CREB1;PDE2A
gsea,Synaptic vesicle cycle,-0.2535004151071583,-0.7591409276356887,0.7924528301886793,1.0,1.0,4/78,7.42%,CLTB;ATP6V0B;AP2S1;ATP6V1G1
gsea,Apoptosis,-0.2070209349069938,-0.7586360729323349,0.775,1.0,1.0,24/142,21.26%,CASP6;GADD45A;TRADD;LMNA;CTSF;PIK3CD;MAPK3;BBC3;CFLAR;CAPN1;BAX;ACTG1;BOK;GADD45B;MAP2K2;BAK1;CTSZ;AKT2;BAD;RIPK1;DAB2IP;DDIT3;TRAF2;TNFRSF10B
gsea,Neutrophil extracellular trap formation,0.18899537831763072,0.7569894138901186,0.9,1.0,1.0,7/189,11.66%,SLC25A5;HMGB1;CLCN3;VDAC3;MAP2K1;PIK3CB;HDAC3
gsea,Small cell lung cancer,0.20787593844328386,0.7565065358322726,0.8214285714285714,1.0,1.0,17/92,25.64%,CDK2;E2F1;FN1;CDK6;PIK3CB;DDB2;LAMC1;RB1;CKS1B;ITGB1;ITGA6;ITGA3;E2F3;CYCS;LAMA5;LAMA3;CCNE1
gsea,Pathogenic Escherichia coli infection,-0.18424418618620075,-0.7554333869490814,0.9387755102040817,1.0,1.0,28/197,17.50%,TRADD;MYH9;PTPN6;MAPK3;LPAR2;SEC24C;ARPC5;BRK1;RAB1A;PYCARD;CYTH1;BAX;TAB1;ACTG1;ARHGEF1;ABI1;CYTH2;TAB2;CLDN4;MAPK13;MAPK14;CLDN7;CLDN23;BAK1;MYO1C;MAPK11;ACTR3C;IL6
gsea,Insulin secretion,0.24912397429701946,0.7524890407958235,0.7627118644067796,1.0,1.0,8/86,21.29%,ATP1B3;ADCY3;ATP1B1;GNAQ;GNAS;PRKACB;ATP1A1;CREB1
gsea,Ras signaling pathway,0.172923932906266,0.7524256324824273,0.8846153846153846,1.0,1.0,29/232,25.16%,MAP2K1;STK4;SOS1;SYNGAP1;PIK3CB;ETS2;RAP1B;KITLG;TBK1;PTPN11;RALB;GNG12;PLA2G12A;RHOA;MAPK1;NRAS;GNB4;PRKACB;VEGFA;EXOC2;BRAP;SHOC2;KRAS;RASGRP1;MAPK8;RASAL2;RAB5C;PAK2;RAP1A
gsea,Acute myeloid leukemia,0.22444078233517686,0.751254566656409,0.8245614035087719,1.0,1.0,15/67,29.90%,MAP2K1;SOS1;PIK3CB;STAT5B;MAPK1;TCF7;NRAS;RUNX1;KRAS;PPARD;MTOR;RPS6KB2;RAF1;PIK3CA;CHUK
gsea,Rap1 signaling pathway,-0.18308969848261017,-0.7463936196940741,0.8888888888888888,1.0,1.0,29/210,22.68%,RAPGEF2;PIK3CD;MAPK3;LPAR2;EGFR;BCAR1;EFNA4;RRAS;ACTG1;THBS1;VASP;PDGFC;MAP2K2;MAPK13;RAPGEF1;MAPK14;AFDN;PDGFB;CSF1;MAPK11;AKT2;PRKCZ;ADCY6;ITGAM;EFNA1;SIPA1L3;PARD6B;PRKCG;CALM3
gsea,Circadian entrainment,0.2542455745541292,0.7434234483855982,0.8333333333333334,1.0,1.0,8/97,21.29%,ADCY3;GNG12;MAPK1;GNAQ;GNAS;GNB4;PRKACB;CREB1
gsea,Parkinson disease,0.2055630695633803,0.7385811981088227,0.7017543859649122,1.0,1.0,47/249,23.80%,SLC25A5;UQCRFS1;TUBB;UCHL1;TUBA1B;PSMD14;PSMD6;PSMB2;UBA1;ENST00000639558.1;VDAC3;PSMD1;KIF5B;NDUFS1;PSMA5;PSMD11;PSMA4;PSMA3;PARK7;TUBB4B;PSMD7;HSPA5;TUBA4A;ENST00000629691.2;MCU;RPS27A;ATP5PF;UBE2G1;PSMC6;EIF2S1;NDUFB5;PSMA1;TRAP1;GNAS;PSMB3;PRKACB;XBP1;TUBB2A;PSMC3;ATP5PO;NFE2L2;COX7B;CYCS;TXN;MAPK8;COX7A2L;SDHB
gsea,GnRH signaling pathway,-0.1849665306929861,-0.7360412393094955,0.8604651162790697,1.0,1.0,11/93,17.38%,PLD2;MMP14;MAPK3;EGFR;LHB;MAP2K2;PTK2B;MAPK13;MAPK14;MAPK11;ADCY6
gsea,ECM-receptor interaction,0.24068257877892074,0.7338007312789634,0.7407407407407407,1.0,1.0,12/88,28.16%,FN1;HMMR;LAMC1;ITGB1;ITGA6;ITGA3;ITGB4;LAMA5;SDC1;LAMA3;SPP1;ITGA5
gsea,GnRH secretion,-0.20877024410624984,-0.7334056744853439,0.8974358974358975,1.0,1.0,7/64,16.62%,PIK3CD;MAPK3;LHB;MAP2K2;ARRB2;AKT2;ARRB1
gsea,JAK-STAT signaling pathway,0.22173853113348557,0.7285579365077305,0.8372093023255814,1.0,1.0,16/162,24.04%,CCND3;SOS1;JAK1;PIK3CB;OSMR;PTPN11;PIAS1;STAT1;STAT5B;IL13RA1;IL4R;STAM;PTPN2;IL10RB;IFNAR1;MTOR
gsea,Choline metabolism in cancer,0.18730267760883407,0.7251965005643537,0.9137931034482759,1.0,1.0,19/98,27.91%,SLC44A1;MAP2K1;SOS1;PIK3CB;PLPP1;SLC44A2;PIP5K1A;CHPT1;MAPK1;NRAS;HIF1A;PDPK1;DGKG;KRAS;MAPK8;MTOR;RPS6KB2;RAF1;PIK3CA
gsea,Tight junction,0.18625896703000502,0.7246740499674919,0.8490566037735849,1.0,1.0,21/169,18.91%,PCNA;TUBA1B;ARPC2;PRKCI;MYH14;RAB8A;HSPA4;ROCK2;MSN;PPP2CA;PPP2R1B;ACTR2;TUBA4A;ACTR3;RHOA;ARPC3;ITGB1;ROCK1;RUNX1;PRKACB;PRKAA1
gsea,Arrhythmogenic right ventricular cardiomyopathy,-0.22819842405464577,-0.7243065257440822,0.8727272727272727,1.0,1.0,6/77,14.28%,LMNA;ATP2A2;JUP;ACTG1;CACNB3;DAG1
gsea,Axon guidance,-0.19925496971427095,-0.7242204583843975,0.86,1.0,1.0,30/182,25.07%,EPHB4;SRGAP2;PIK3CD;MAPK3;NFATC3;WNT5A;PTCH1;EFNA4;RRAS;PLXNB1;RND1;DCC;CDK5;PRKCZ;SSH2;SEMA7A;ARHGEF12;RASA1;EFNA1;MYL5;LIMK2;SEMA3B;PARD6B;WNT5B;MYL12B;NCK1;SEMA4C;ILK;PPP3CA;MYL9
gsea,Longevity regulating pathway,0.1788799489814259,0.7240526341815638,0.9636363636363636,1.0,1.0,19/102,27.91%,ENST00000645126.2;HSPA8;EIF4E;PIK3CB;APPL1;ADCY3;NRAS;PRKACB;HDAC2;PRKAA1;CREB1;KRAS;EHMT1;MTOR;RPS6KB2;CAMKK2;ADIPOR1;RPTOR;PIK3CA
gsea,Renin secretion,0.2564601344054174,0.7222706674251488,0.8695652173913043,1.0,1.0,5/69,21.29%,PPP3R1;GNAQ;GNAS;PRKACB;CREB1
gsea,Shigellosis,0.16288316952547102,0.7206240951688915,0.9583333333333334,1.0,1.0,39/246,24.68%,FNBP1;ARPC2;UBE2V2;U2AF1;HKDC1;ROCK2;PFN2;PIK3CB;BCL10;WASL;U2AF1L5;DIAPH1;ACTR2;TBK1;ACTR3;CAPNS1;PIK3C3;RPS27A;VCL;CRK;PFN1;PIK3R4;RHOA;MAPK1;ARPC3;ITGB1;ROCK1;TNIP1;ARPC1A;MAPK12;RIPK2;SKP1;CYCS;GSK3B;MAPK8;CRKL;CUL1;MTOR;UBE2N
gsea,Adrenergic signaling in cardiomyocytes,0.21258946719801766,0.7203240578578808,0.8163265306122449,1.0,1.0,15/150,21.29%,PPP1CC;ATP1B3;PPP2CA;PPP1CA;PPP2R1B;ADCY3;PPP2R5A;ATP1B1;MAPK1;GNAQ;GNAS;PRKACB;ATP1A1;MAPK12;CREB1
gsea,FoxO signaling pathway,-0.19739585364196666,-0.7193083368488867,0.8333333333333334,1.0,1.0,21/131,18.13%,GADD45A;CDKN2B;FOXO4;PIK3CD;MAPK3;CAT;EGFR;IRS2;HOMER3;USP7;PRKAG1;GADD45B;MAP2K2;FBXO32;GABARAPL1;MAPK13;MAPK14;MAPK11;AKT2;IL6;SMAD4
gsea,Rheumatoid arthritis,-0.23202376906214253,-0.7169268751376082,0.9069767441860465,1.0,1.0,13/93,30.72%,ATP6V0B;ATP6V1G1;HLA-DMA;CSF1;IL23A;IL6;IL18;ATP6AP1;ICAM1;CTSL;TNFSF13;TCIRG1;HLA-DQB1
gsea,Calcium signaling pathway,0.18531891760421246,0.7168031976246744,0.9444444444444444,1.0,1.0,13/240,20.10%,SLC25A5;GRPR;PPP3R1;VDAC3;MCU;ADCY3;ADORA2B;GNAQ;GNAS;ASPH;PRKACB;VEGFA;PTAFR
gsea,Inflammatory mediator regulation of TRP channels,0.21120433024850388,0.7151613730424887,0.88,1.0,1.0,10/98,23.39%,PPP1CC;PPP1CA;PIK3CB;ADCY3;GNAQ;GNAS;PRKACB;F2RL1;MAPK12;MAPK8
gsea,Vibrio cholerae infection,0.2511458952475474,0.714672381490055,0.7884615384615384,1.0,1.0,22/50,42.38%,ATP6V1C1;ADCY3;SEC61G;ATP6V0E2;GNAS;PRKACB;KDELR3;ERO1A;PDIA4;ATP6V0E1;ATP6V0A1;ACTB;ATP6V1E1;ATP6V1D;ATP6V1A;SEC61B;ARF1;SEC61A1;ATP6V0D1;ATP6V0C;PRKCA;ATP6V1B2
gsea,Glioma,-0.1971029156888513,-0.7125330566795555,0.8936170212765957,1.0,1.0,11/75,16.51%,GADD45A;PIK3CD;MAPK3;EGFR;BAX;CDKN2A;GADD45B;MAP2K2;BAK1;PDGFB;AKT2
gsea,NOD-like receptor signaling pathway,0.17503825025012748,0.7124199579957803,0.9318181818181818,1.0,1.0,21/181,23.39%,YWHAE;OAS3;HSP90AA1;VDAC3;DNM1L;JAK1;TBK1;NEK7;MCU;STAT1;RHOA;HSP90AB1;MAPK1;SUGT1;GBP3;MAPK12;RIPK2;IFNAR1;TXN;TRPM7;MAPK8
gsea,Human papillomavirus infection,0.1714972975447842,0.7097252052553404,0.9583333333333334,1.0,1.0,49/331,25.72%,CDK2;TUBG1;E2F1;FN1;PRKCI;CCND3;MAP2K1;CDK6;PPP2CA;SOS1;JAK1;PPP2R1B;PIK3CB;UBR4;TBK1;ATP6V1C1;STAT1;PPP2R5A;LAMC1;MAPK1;ATP6V0E2;RB1;GNAS;ITGB1;TCF7;ITGA6;NRAS;ITGA3;NOTCH1;PRKACB;EIF2AK2;HDAC2;VEGFA;ITGB4;PKM;CREB1;ATP6V0E1;IFNAR1;RBPJ;GSK3B;KRAS;MTOR;ATR;LAMA5;RPS6KB2;LAMA3;SPP1;CCNE1;ATP6V0A1
gsea,Serotonergic synapse,0.2255884294618991,0.7094967363958504,0.875,1.0,1.0,8/113,18.71%,MAP2K1;GNG12;MAPK1;GNAQ;GNAS;NRAS;GNB4;PRKACB
gsea,Pancreatic cancer,-0.18636315611509607,-0.708181037946693,0.851063829787234,1.0,1.0,13/76,18.13%,GADD45A;PLD2;PIK3CD;MAPK3;EGFR;ERBB2;BAX;CDKN2A;GADD45B;BAK1;AKT2;BAD;SMAD4
gsea,Hematopoietic cell lineage,0.25024014738505773,0.7066117192494605,0.78,1.0,1.0,6/99,18.41%,TFRC;ANPEP;KITLG;ITGA6;ITGA3;IL4R
gsea,ErbB signaling pathway,0.18846223146298918,0.7049886971912062,0.86,1.0,1.0,17/85,27.91%,MAP2K4;MAP2K1;SOS1;PIK3CB;CRK;STAT5B;MAPK1;NRAS;GSK3B;KRAS;MAPK8;CRKL;MTOR;PAK2;RPS6KB2;RAF1;PIK3CA
gsea,T cell receptor signaling pathway,0.17988895407165245,0.7043758951599394,0.88,1.0,1.0,15/104,24.31%,PPP3R1;MAP2K1;SOS1;PIK3CB;BCL10;RHOA;MAPK1;NRAS;MAPK12;PDPK1;GSK3B;KRAS;RASGRP1;MAPK8;PAK2
gsea,Hippo signaling pathway,0.17239100717904945,0.70406441353677,0.875,1.0,1.0,21/163,24.63%,YWHAE;PPP1CC;PRKCI;YWHAH;CCND3;PPP2CA;CSNK1E;ID1;PPP1CA;PPP2R1B;YWHAZ;MOB1A;BIRC5;STK3;TCF7;BMP4;YWHAB;CDH1;GSK3B;TEAD4;YWHAQ
gsea,Cell adhesion molecules,-0.2168306956644979,-0.7027901494801987,0.8695652173913043,1.0,1.0,11/148,18.97%,CD99L2;VSIR;HLA-C;CD99;CLDN4;CLDN7;CLDN23;HLA-DMA;SDC4;PTPRM;ITGAM
gsea,IL-17 signaling pathway,-0.20044443638256929,-0.6952339845905395,0.9245283018867925,1.0,1.0,17/94,25.27%,TRADD;MAPK3;JUND;TAB2;CEBPB;MAPK13;MAPK14;MAPK11;PTGS2;IL6;LCN2;TRAF2;TRAF4;NFKBIA;FADD;TAB3;CASP3
gsea,Legionellosis,0.2064753930220497,0.6924945599947661,0.9,1.0,1.0,8/57,23.81%,HSPD1;HSPA8;HBS1L;SAR1B;VCP;CYCS;CLK1;BCL2L13
gsea,Prion disease,0.19338039001702176,0.6874956788206446,0.8421052631578947,1.0,1.0,47/273,23.80%,SLC25A5;UQCRFS1;TUBB;TUBA1B;HSPA8;PSMD14;STIP1;PSMD6;PSMB2;PPP3R1;ENST00000639558.1;VDAC3;PSMD1;KIF5B;NDUFS1;PSMA5;PSMD11;PSMA4;PSMA3;PIK3CB;TUBB4B;PSMD7;HSPA5;TUBA4A;ENST00000629691.2;MCU;ATP5PF;PSMC6;EIF2S1;LAMC1;NDUFB5;PSMA1;MAPK1;PSMB3;NOTCH1;PRKACB;MAPK12;TUBB2A;CREB1;PSMC3;ATP5PO;COX7B;CYCS;GSK3B;MAPK8;COX7A2L;SDHB
gsea,Toxoplasmosis,0.19186651610761102,0.6815630785667439,0.9038461538461539,1.0,1.0,23/112,36.13%,HSPA8;JAK1;LDLR;STAT1;LAMC1;MAPK1;ITGB1;ITGA6;MAPK12;PDPK1;IL10RB;CYCS;MAPK8;LAMA5;LAMA3;CHUK;LAMC2;MAP3K7;IRAK1;BIRC2;BIRC3;XIAP;TYK2
gsea,cAMP signaling pathway,0.18373005245195168,0.68038539760804,0.9574468085106383,1.0,1.0,17/216,21.29%,PPP1CC;ATP1B3;MAP2K1;ROCK2;PPP1CA;PIK3CB;RAP1B;ADCY3;ATP1B1;RHOA;MAPK1;GNAS;ROCK1;PRKACB;ATP1A1;PPP1R12A;CREB1
gsea,SNARE interactions in vesicular transport,-0.23073583026064226,-0.6800491994776728,0.875,1.0,1.0,5/33,10.68%,VAMP8;STX4;SNAP23;STX16;BET1L
gsea,Insulin resistance,-0.1656295426762151,-0.679581191629258,0.9464285714285714,1.0,1.0,12/108,17.50%,ENST00000629738.3;NR1H3;PIK3CD;NR1H2;IRS2;SLC27A1;PRKAG1;AKT2;MLX;PRKCZ;CPT1A;IL6
gsea,Human cytomegalovirus infection,0.1603993090491259,0.6793671053288921,0.9807692307692307,1.0,1.0,32/225,24.04%,E2F1;PPP3R1;MAP2K1;ROCK2;CDK6;SOS1;JAK1;PIK3CB;TBK1;ADCY3;CRK;GNG12;RHOA;MAPK1;GNAQ;RB1;GNAS;ROCK1;NRAS;GNB4;PRKACB;VEGFA;E2F3;MAPK12;BID;CREB1;IL10RB;CYCS;GSK3B;KRAS;CRKL;MTOR
gsea,PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.18853431552243272,-0.6786062827943462,0.8541666666666666,1.0,1.0,11/89,16.51%,PTPN6;TICAM1;PIK3CD;MAPK3;EGFR;NFATC3;MAP2K2;MAPK13;MAPK14;MAPK11;AKT2
gsea,MicroRNAs in cancer,0.16616060212170763,0.6746555501447915,0.9444444444444444,1.0,1.0,32/310,28.16%,CDC25A;BRCA1;E2F1;HMGA2;CDCA5;MAP2K1;CDK6;SOS1;EZH2;GLS;PIK3CB;CDC25C;CRK;RHOA;MAPK1;ROCK1;NRAS;NOTCH1;HDAC2;VEGFA;E2F3;SERPINB5;SLC7A1;KRAS;CRKL;MTOR;CCNE1;HMOX1;RAF1;RPTOR;PIK3CA;ITGA5
gsea,Collecting duct acid secretion,0.24489504764909076,0.669384600025734,0.94,1.0,1.0,10/27,42.38%,ATP6V1C1;ATP6V0E2;ATP6V0E1;ATP6V0A1;ATP6V1E1;ATP6V1D;ATP6V1A;ATP6V0D1;ATP6V0C;ATP6V1B2
gsea,Fructose and mannose metabolism,0.2751564969047765,0.668447642432935,0.9107142857142857,1.0,1.0,4/33,15.98%,ALDOA;HKDC1;SORD;TPI1
gsea,Fluid shear stress and atherosclerosis,0.15696639177136848,0.6681242398720907,0.9622641509433962,1.0,1.0,32/139,37.47%,MAP2K4;HSP90B1;HSP90AA1;PIK3CB;RHOA;HSP90AB1;BMP4;PRKAA1;VEGFA;MAPK12;NFE2L2;TXN;MAPK8;SDC1;HMOX1;PIK3CA;MGST1;SUMO1;CHUK;KLF2;SUMO3;NCF2;PTK2;ACTB;TXN2;IL1R2;MAP3K7;CAV2;CALM1;RAC1;CALM2;BMPR2
gsea,Neuroactive ligand-receptor interaction,-0.19607212815314407,-0.6679695828669404,0.9230769230769231,1.0,1.0,11/341,21.57%,LPAR2;P2RY2;LHB;VIPR1;P2RX4;GABRP;TSPO;P2RX5;ADM;TAC4;S1PR2
gsea,Melanogenesis,0.169765577992094,0.6669999117974195,1.0,0.9958892065896937,1.0,12/101,23.29%,MAP2K1;KITLG;ADCY3;MAPK1;GNAQ;GNAS;TCF7;NRAS;PRKACB;CREB1;GSK3B;KRAS
gsea,Colorectal cancer,-0.1740692434794255,-0.664820658457641,0.9555555555555556,1.0,1.0,14/86,18.13%,GADD45A;PIK3CD;MAPK3;BBC3;EGFR;BAX;GADD45B;DCC;MAP2K2;BAK1;AKT2;BAD;MYC;SMAD4
gsea,Th1 and Th2 cell differentiation,0.198177554740123,0.6602545137735698,0.9387755102040817,0.9967896493319167,1.0,10/92,23.39%,PPP3R1;JAK1;STAT1;STAT5B;MAPK1;IL4R;NOTCH1;MAPK12;RBPJ;MAPK8
gsea,Transcriptional misregulation in cancer,-0.1801834939657311,-0.6596174635577147,1.0,1.0,1.0,18/192,20.47%,GADD45A;MEN1;BAX;EWSR1;JUP;SPINT1;GADD45B;MLLT1;CEBPB;BAK1;LDB1;JMJD1C;MYC;PBX1;IL6;ITGAM;TFE3;DDIT3
gsea,Neurotrophin signaling pathway,-0.1675778687231626,-0.6524379158166319,0.9777777777777777,1.0,1.0,15/119,16.72%,SH2B1;PIK3CD;MAPK3;BEX3;MAPKAPK2;BAX;NTF4;ZNF274;MAP2K2;MAPK13;RAPGEF1;MAPK14;MAPK11;AKT2;BAD
gsea,Salivary secretion,0.2412758690717162,0.651011177286816,0.8490566037735849,0.9998328356783246,1.0,7/93,19.11%,ATP1B3;ADCY3;ATP1B1;GNAQ;GNAS;PRKACB;ATP1A1
gsea,Type II diabetes mellitus,0.21073516446795973,0.6498426165180939,0.9069767441860465,0.9948331018984725,1.0,7/46,27.91%,HKDC1;PIK3CB;MAPK1;PKM;MAPK8;MTOR;PIK3CA
gsea,B cell receptor signaling pathway,-0.18277750539496623,-0.6353812754030247,0.9230769230769231,1.0,1.0,8/81,16.51%,PTPN6;PIK3CD;MAPK3;NFATC3;INPPL1;MAP2K2;IFITM1;AKT2
gsea,Relaxin signaling pathway,0.16557291995667892,0.6296711058263904,0.9636363636363636,1.0,1.0,16/129,23.39%,MAP2K4;MAP2K1;SOS1;PIK3CB;ADCY3;GNG12;MAPK1;GNAS;NRAS;GNB4;PRKACB;VEGFA;MAPK12;CREB1;KRAS;MAPK8
gsea,Breast cancer,-0.1600101105722895,-0.6263644722740846,0.9565217391304348,1.0,1.0,15/147,17.05%,GADD45A;PIK3CD;MAPK3;EGFR;WNT5A;ERBB2;BAX;DVL2;FRAT2;GADD45B;MAP2K2;BAK1;DVL1;AKT2;MYC
gsea,Adipocytokine signaling pathway,0.17942449410131728,0.6263581510655111,0.9782608695652174,1.0,1.0,11/69,29.90%,ENST00000645126.2;ACSL3;PTPN11;PRKAA1;MAPK8;MTOR;SLC2A1;CAMKK2;ADIPOR1;PPARA;CHUK
gsea,Viral myocarditis,-0.2108459407628451,-0.6212286129117496,0.9387755102040817,1.0,1.0,26/60,78.98%,ACTG1;HLA-C;EIF4G2;DAG1;HLA-DMA;CASP3;ICAM1;RAC2;HLA-DQB1;CD40;CD55;HLA-E;ABL2;FYN;RAC3;CCND1;CASP8;CAV1;RAC1;ABL1;HLA-B;ACTB;EIF4G1;EIF4G3;CYCS;BID
gsea,Cholesterol metabolism,0.23951389072685686,0.6130485097882585,0.9,1.0,1.0,13/50,39.45%,VDAC3;SOAT1;NCEH1;LDLR;NPC1;APOC1;LIPG;PCSK9;VAPA;SORT1;LIPA;VDAC1;VAPB
gsea,Adherens junction,-0.16959714948641288,-0.6102463735390425,1.0,1.0,1.0,23/71,33.15%,PTPN6;MAPK3;EGFR;ERBB2;ACTG1;YES1;AFDN;NECTIN4;PTPRM;SMAD4;PTPRF;CSNK2A2;PTPRB;SNAI2;CTNNB1;RAC2;IGF1R;PTPN1;PTPRJ;TJP1;CSNK2A1;ACP1;ACTN4
gsea,mTOR signaling pathway,0.1288831048830862,0.5986180119966833,1.0,1.0,1.0,24/154,27.91%,SEH1L;LPIN1;SLC7A5;EIF4E;MAP2K1;SOS1;PIK3CB;SLC3A2;ATP6V1C1;STRADB;RHOA;MAPK1;NRAS;PRKAA1;PDPK1;RPS6KA3;GSK3B;CAB39;KRAS;MTOR;RPS6KB2;RAF1;RPTOR;PIK3CA
gsea,Proteoglycans in cancer,-0.13493264293238594,-0.594722785448717,0.9782608695652174,1.0,1.0,47/205,31.19%,PTPN6;CD63;PIK3CD;MAPK3;EGFR;WNT5A;PTCH1;ERBB2;RRAS;ACTG1;ARHGEF1;PPP1R12C;THBS1;MAP2K2;MAPK13;MAPK14;MAPK11;PXN;AKT2;MYC;SDC4;FZD7;ARHGEF12;WNT5B;PRKCG;GRB2;FZD2;WNT6;PPP1CB;CASP3;DROSHA;ITGB5;NUDT16L1;EIF4B;RPS6;CTSL;RRAS2;WNT7B;TP53;CTNNB1;WNT10A;TIMP3;PLCG1;PDCD4;IGF1R;ERBB3;HRAS
gsea,Glycerolipid metabolism,0.1797752185243606,0.5911032594356321,1.0,1.0,1.0,11/61,31.15%,LPIN1;ALDH2;PLPP1;ALDH9A1;AGK;GLA;DGKG;MBOAT2;PNPLA3;LIPG;GPAT3
gsea,Glucagon signaling pathway,0.17553815557599226,0.5845189932693251,0.9555555555555556,1.0,1.0,24/107,37.99%,PPP3R1;LDHA;PDHA1;PRMT1;LDHB;GNAQ;GNAS;PRKACB;PRKAA1;PKM;ACACA;CREB1;PGAM1;SLC2A1;PPARA;PFKL;PHKA2;ITPR3;GYS1;FBP1;PRKAB1;CALM1;CALM2;EP300
gsea,Protein digestion and absorption,0.20328400500239732,0.5833387323676335,0.8703703703703703,0.9964432688332666,1.0,5/103,19.11%,ATP1B3;SLC3A2;ATP1B1;SLC1A5;ATP1A1
gsea,Natural killer cell mediated cytotoxicity,0.15516695414622295,0.5677212934107948,1.0,0.996684900524715,1.0,13/131,28.30%,PPP3R1;MAP2K1;SOS1;PIK3CB;PTPN11;MAPK1;NRAS;BID;IFNAR1;KRAS;RAF1;PIK3CA;TNFRSF10A
gsea,Inflammatory bowel disease,-0.25287761718787594,-0.5634789633340495,0.9090909090909091,1.0,1.0,7/65,30.72%,HLA-DMA;STAT6;IL23A;IL6;IL18;IFNGR2;HLA-DQB1
gsea,Tuberculosis,0.1427938769319856,0.5549993413332708,0.9803921568627451,0.9954911104587203,1.0,19/180,23.75%,HSPD1;HSPA9;PPP3R1;JAK1;BCL10;PIK3C3;STAT1;RHOA;MAPK1;MAPK12;BID;RIPK2;CREB1;LSP1;IL10RB;CYCS;RAB7A;MAPK8;RAB5C
gsea,Chagas disease,-0.14976689320063913,-0.5509871435714775,1.0,1.0,1.0,9/102,17.50%,TICAM1;PIK3CD;MAPK3;CFLAR;MAPK13;MAPK14;MAPK11;AKT2;IL6
gsea,AGE-RAGE signaling pathway in diabetic complications,-0.14640364166960343,-0.5508422171027375,0.9777777777777777,0.9916734564680918,1.0,11/100,18.13%,PIK3CD;MAPK3;BAX;COL4A5;MAPK13;MAPK14;MAPK11;AKT2;PRKCZ;IL6;SMAD4
gsea,Basal transcription factors,-0.1481253822854865,-0.5303837360246624,1.0,0.9845309761487465,1.0,3/45,9.11%,GTF2H5;TAF6L;GTF2F1
gsea,Cocaine addiction,0.18698643108448082,0.4922091137454274,0.9807692307692307,1.0,1.0,3/49,21.29%,GNAS;PRKACB;CREB1
gsea,Epithelial cell signaling in Helicobacter pylori infection,0.12663811607964615,0.4456860509066773,1.0,1.0,1.0,10/70,27.03%,MAP2K4;ADAM17;PTPN11;ATP6V1C1;ATP6V0E2;MAPK12;ATP6V0E1;MAPK8;ATP6V0A1;CSK
gsea,Herpes simplex virus 1 infection,0.10931657575696554,0.42502771549085844,1.0,0.9982933887363656,1.0,46/498,36.19%,OAS3;EIF2AK4;PPP1CC;SRSF1;SRSF7;PPP1CA;JAK1;PIK3CB;ZNF417;TBK1;PTPN11;STAT1;SRSF4;EIF2S1;ZNF268;EIF2AK2;ZNF468;ZNF506;BID;SRPK1;ZNF600;IFNAR1;ZNF480;CYCS;MTOR;ZNF761;EIF2B1;ZNF621;PIK3CA;ITGA5;ZNF689;CHUK;EIF2AK1;ZNF841;HLA-B;ZNF587;CGAS;MAP3K7;ZNF778;IRAK1;BIRC2;BIRC3;ZNF33B;ZNF766;TYK2;ALYREF
